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Abstract 
 
Forward metabolic engineering (FME) is a rational approach to 
cellular engineering, relying on an understanding of the entire 
metabolic network to direct perturbations for phenotype 
improvement.  Conversely, inverse metabolic engineering (IME) 
uses a global, combinatorial approach to identify genetic loci 
that are important for a given phenotype.  These two approaches 
complement each other in a strain improvement program.  FME and 
IME approaches were applied to poly-3-hydroxybutyrate (PHB) 
production in Synechocystis PCC6803 [IME] and recombinant E. 
coli [FME] in this thesis.   
 
IME was appropriate for Synechocystis, where metabolic 
regulation of the native PHB pathway was not well understood.  A 
high throughput screening method was established by developing a 
staining protocol that quantitatively related nile red 
fluorescence to PHB content, while maintaining cell viability 
for both organisms. This was combined with fluorescence 
activated cell sorting (FACS) to screen for high PHB mutants.  A 
Synechocystis insertion mutagenesis library was screened to 
identify gene disruptions that increased PHB.  Two gene 
disruptions in proline biosynthesis and an unknown function were 
identified and characterized.   
 
An analogous IME study in E. coli did not find increased PHB 
mutants, but suggested an FME approach on the PHB pathway.  
Systematic overexpression of the pathway revealed phaB, 
acetoacetyl-CoA reductase, limited PHB flux.  Beyond this, whole 
operon overexpression led to even higher PHB fluxes.  In a 
nitrogen-limited chemostat, PHB flux did not change with 
dilution rate.  Unlike prior pleiotropic perturbations, these 
systematic experiments could clearly conclude that the flux 
control is in the PHB pathway. 
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At high PHB flux, growth rate was extremely hindered and was 
accompanied by PHB plasmid genetic instability and rapid PHB 
productivity loss.  Tandem gene duplication (TGD) was developed 
to slow productivity loss caused by “allele segregation,” a fast 
process that propagates a DNA mutation to all copies of a 
plasmid.  By placing the many copies in tandem, rather than on 
individual plasmids, allele segregation could be avoided, 
increasing stability significantly.   
 
These methods and results should support PHB engineering in 
higher photosynthetic organisms and better E. coli PHB 
production in batch or continuous culture.  TGD is a broadly 
applicable technique for high level recombinant expression. 
 
 
Thesis Supervisor: Gregory Stephanopoulos 
Title: Willard Henry Dow Professor of Chemical Engineering 
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1 Introduction 
Strain engineering and optimization is a central problem in 
biotech applications.  Genetic manipulation of an organism to 
yield a strain that is superior to the wild type with regard to 
a particular phenotype is the goal of strain improvement 
programs.  Retrofitting evolution to give us more of a 
particular metabolite/protein or resistance to a higher 
temperature/pH allows us to use living organisms in specialized 
applications to benefit mankind.  A variety of tactics have been 
employed to optimize strains for the production of compound of 
interest. 
It has been shown time and time again that for recombinant 
production of a compound of interest, the productivity of an 
organism is not only determined by the activity of the product-
forming step, but is a function of the pathway in its entirety 
(Niederberger, Prasad R et al. 1992; Fell and Thomas 1995; 
Sudesh, Taguchi et al. 2002).  In the cited examples, increased 
activity in individual steps of the pathway was not able to 
increase the flux through the pathway.  As well, many distal 
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factors may affect the flux through the product-forming pathway: 
competing pathways, physiological effects of the accumulation of 
the product or intermediate metabolites, redox state, co-factor 
availability, and more (Burgard, Pharkya et al. 2003; Alper, 
Miyaoku et al. 2005; Alper, Moxley et al. 2006).  These factors 
must be taken into consideration when trying to improve the 
productivity of an organism.  
In practice, engineering cells can be limited because the 
aforementioned effects may be difficult to identify.  Random 
approaches, such as genome shuffling, chemical mutagenesis, and 
unnatural evolution, have been used to generate genetic 
diversity that may contain improved strains (Crameri, Raillard 
et al. 1998; Parekh, Vinci et al. 2000).  These combinatorial 
methods in conjunction with an effective selection/screen are a 
powerful way to improve cell performance.  However, these 
techniques often do not provide insight into the cell biology.  
Although an improved strain is isolated, further development of 
the strain is difficult because the genetic changes may not be 
obvious.  Strategies that attempt to close this loop by 
employing tools that control the number of mutations and make 
the locations more readily identified is therefore necessary. 
A two-pronged complementary approach of (a) forward, or 
traditional, metabolic engineering (FME) that measures and 
analyzes what is known about the metabolic pathways and the 
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system as a whole to direct genetic changes, combined with (b) 
inverse metabolic engineering (IME), which seeks to identify 
previously unknown mechanisms for improving flux to the desired 
product, offers a way forward that leverages current knowledge 
of the system, while seeking to add relevant knowledge.   
The challenge then is to develop methods for each of these 
two avenues of strain development.  For FME, more (and 
specifically more relevant) knowledge obtained through the 
systematic analysis of metabolic pathways will move our 
knowledge beyond which enzymes are involved in the pathway to 
which enzymes play the most dominant role in controlling the 
flux to the desired product.  For IME, experimental methods to 
introduce genetic diversity into the desired organism and high 
throughput methods for identifying clones from the diversity 
that result in improved phenotypes will lead to the 
identification of unpredicted genetic loci that will expand our 
understanding of the system.   
Another key challenge is the dynamic nature of DNA, and the 
loss of productivity of the compound of interest that 
accompanies DNA mutations in engineered organisms.  Organisms 
which grow faster will overtake a given population.  Typically 
production of a desired molecule results in reduced fitness for 
an organism.  Therefore, mutants that evolve in a way that 
mitigates the product formation will grow faster and overtake 
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the culture.  In batch processes, these problems can be reduced 
by minimizing the number of generations that are allowed to grow.  
However, this is not the case in production schemes that require 
many cell divisions during production, such as chemostats. 
These questions can not be addresses in the abstract, and 
therefore, a model system must be used that is appropriate to 
explore these ideas and develop methods for gathering the 
desired information and achieving the desired strain properties. 
Improving the accumulation of the biopolymer poly-3-
hydroxybutyrate (PHB) by the cyanobacterium Synechocystis PCC680 
and Escherichia coli would have significant ecological and 
economical implications, that will be discussed in Chapter 2.    
Synechocystis naturally synthesizes the biopolymer from carbon 
dioxide and light, allowing direct conversion to the desired 
product.  PHB production in Synechocystis uses native genes and 
is subject to internal regulation that has not been elucidated.  
PHB production in E. coli is based on the heterologous 
expression of the PHB pathway and is not subject to native 
regulation.  Although it requires sugars or fatty acids (and 
thereby another photosynthetic organism to provide these 
materials) to generate PHB, it has much higher productivities in 
general than photosynthetic organisms and has much better 
understood metabolism. 
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1.1. Thesis objectives 
The objective of this thesis is to identify genetic loci 
that affect the production of poly-3-hydroxybutyrate in 
Synechocystis and E. coli by developing the necessary methods to 
obtain this information and improve the productivity and genetic 
stability of PHB production using the paradigms of forward and 
inverse metabolic engineering. 
1.2. Specific aims 
In pursuance of the above mentioned general goals, the 
follows specific aims were pursued based on two bioengineering 
approaches, (1) inverse metabolic engineering and (2) forward 
(or traditional) metabolic engineering.  
 Inverse Metabolic Engineering 
a. Develop libraries of genetic diversity in 
Synechocystis and E. coli.   
b. Develop a high throughput screen for PHB 
accumulation for Synechocystis and E. coli. 
c. Identify genetic loci that contribute to PHB 
production by isolating and characterizing 
library mutants from Aim (a) using the high 
throughput screen developed in Aim (b). 
 Forward Metabolic Engineering 
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a. Analyze PHB production limitations by 
systematically perturbing the enzymes in the PHB 
pathway in E. coli. 
b. Analyze PHB pathway precursor availability and 
genetic stability by perturbing the overall PHB 
pathway in E. coli. 
c. Analyze PHB productivity by varying growth rates 
in a nitrogen-limited chemostat. 
d. Develop methods for the genetically stable, high 
expression of the PHB operon in E. coli. 
1.3. Thesis organization 
A background on metabolic engineering principles, both 
forward and inverse are presented in Chapter 2, followed by a 
review of PHB focusing on prior efforts to improve PHB 
production in autotrophic and heterotrophic systems. 
While it may seem more natural to discuss forward metabolic 
engineering before inverse metabolic engineering, this thesis 
will be motivated by showing some of the limitations of inverse 
metabolic engineering first that motivated a moved to forward 
approaches. 
Chapters 3 and 4 will focus on the development of tools for 
inverse metabolic engineering and their deployment to 
identifying genetic nodes in Synechocystis.  Chapter 5 will 
 21 
focus on the forward metabolic engineering analysis of E. coli, 
followed by Chapter 6 which will discuss the development of 
tandem gene duplication and its application to improving genetic 
stability.  Chapter 7 will offer concluding thoughts on the 
thesis and next steps that are motivated by the conclusions of 
this work. 
 22 
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2 Background 
This chapter will cover the background both of the 
methodologies pursued in this thesis as well as technical 
details and prior work on engineering poly-3-hydroxybutyrate 
(PHB) production in Synechocystis and E. coli.  Forward and 
inverse metabolic engineering principles will be discussed.  
These principles will motivate the methods developed and the 
data measured in the study, as well as why these approaches are 
appropriate.  Technical details of the PHB pathway and prior 
engineering efforts will reveal what is known, what has been 
attempted, and will reveal the niches of inquiry that will be 
most appropriate. 
2.1. Forward Metabolic Engineering (FME) 
Metabolic engineering is the systematic analysis and 
alteration of metabolic networks, the series of enzymatic 
reactions of the cell that are responsible for the chemistry of 
the cell.  This will be called “forward” metabolic engineering, 
because of the knowledge-driven approach to modifying the 
metabolic network and contrasts well with inverse metabolic 
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engineering, a random approach that generates knowledge, which 
will be discussed later.  Metabolic engineering emerged with the 
advent of recombinant DNA technology (Stephanopoulos 1999).  For 
the first time it was possible to recombine genes from one 
organism with those of another, opening the door to a realm of 
possibilities not yet explored.  While the initial applications 
of genetic engineering were simply producing human proteins in 
bacteria for therapeutic treatment of specific protein 
deficiencies, engineers quickly realized the vast potential of 
using multiple genes to create entirely new pathways that could 
produce a wide range of compounds from a diverse substrate 
portfolio (Bailey 1991; Stephanopoulos and Vallino 1991).  Aided 
by advanced methods for the analysis of biochemical systems, 
metabolic engineering sets out to create new industrial 
innovations based on recombinant DNA technology. 
Metabolic engineering is different from other cellular 
engineering strategies because its systematic approach focuses 
on understanding the larger metabolic network in the cell.  In 
contrast, genetic engineering approaches often only consider 
narrow phenotypic improvements resulting from the manipulation 
of genes directly involved in creating the product of interest.  
The need for a systematic approach to cellular engineering has 
been demonstrated by several vivid examples in which choices for 
improving product formation, such as increasing the activity of 
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the product-forming enzyme, have only resulted in incremental 
improvements in output (Niederberger, Prasad R et al. 1992; Fell 
and Thomas 1995; Sudesh, Taguchi et al. 2002).  Intuitively, 
this makes sense.  A typical cell has evolved to catalyze 
thousands of reactions that serve a multitude of purposes 
critical for maintaining cellular physiology and fitness within 
its environment.  Thus changing pathways that do not improve 
fitness, or even detract from fitness within a population, often 
causes the cell’s regulatory network to adjust by diverting 
resources back to processes that optimize cellular fitness.  
This may lead to relatively small improvements in product 
formation despite large increases in specific enzymatic 
activities.  Without a good understanding of the metabolic 
network, further progress is often difficult to achieve and must 
rely on other time consuming methodologies based on rounds of 
screening for the phenotype of interest.  Classical strain 
improvement (CSI) relies on random mutagenesis to accumulate 
genomic alterations that improve the phenotype (Parekh, Vinci et 
al. 2000).  This method typically has diminishing returns for a 
variety of reasons: 1) it does not extract information about the 
location or nature of the mutagenesis; 2) it often results in 
deleterious mutations alongside advantageous mutations and 
therefore is less efficient, and; 3) it does not harness the 
power of nature’s biodiversity by mixing specialized genes 
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between organisms.  Gene shuffling approaches attempt to correct 
2) and 3) by swapping large pieces of DNA between different 
parental strains to eliminate deleterious mutations or 
incorporate genes from other organisms (Crameri, Raillard et al. 
1998).  In contrast, metabolic engineering approaches embrace 
techniques that fill the gaps left by CSI and gene shuffling 
methodologies by placing an emphasis on understanding the 
mechanistic features that genetic modifications confer, thereby 
adding knowledge that can be used for rational approaches while 
searching the metabolic landscape.   
Metabolic engineering overcomes the shortcomings of 
alternative approaches by considering both the regulatory and 
intracellular reaction networks in detail.  Research on the 
metabolic pathways has primarily focused on the effect of 
substrate uptake, byproduct formation, and other genetic 
manipulations that affect the distribution of intracellular 
chemical reactions (flux).  Because many of the desired products 
are organic molecules, metabolic engineers often concentrate 
their efforts on carbon flow through the metabolic network.  In 
diagnosing the metabolic network, engineers rely on 
intracellular flux measurements conducted in vivo using isotopic 
tracers as opposed to simply using macroscopic variables such as 
growth rate and metabolite exchange rates (Stephanopoulos 1999).  
The latter measurements contain less information about the 
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intracellular reaction network and therefore give a very limited 
perception of the phenotype of the cell.  In vitro enzymatic 
assays can also provide helpful, but potentially misleading, 
information about the behavior of an enzyme in vivo and cannot 
be used to calculate individual fluxes, which also depend upon 
the size of the metabolite pools and other intracellular 
environmental factors.  Research on regulatory networks has 
ranged widely from engineering allosteric regulation, to 
constructing new genetic regulator elements such as promoters, 
activators and repressors that influence the reaction network 
(Lu and Liao 1997; Farmer and Liao 2000; Ostergaard, Olsson et 
al. 2000; Alper, Moxley et al. 2006).  By understanding the 
systemic features of the network, metabolic engineering can 
identify rational gene targets that may not be intuitive when 
relying upon extracellular or activity measurements alone.  In 
practice metabolic engineering studies proceed through a cycle 
of perturbation, measurement, and analysis (Figure 2-1).    
 28 
 
Measurement requires the ability to assay large parts of 
the network to extract as much information about the effect of 
an imposed network perturbation as possible.  GC-MS and NMR are 
commonly used to measure metabolite pools and the rates of 
chemical reactions within cells (Stephanopoulos 1999; Fischer, 
Zamboni et al. 2004; Styczynski, Moxley et al. 2007).  
Measurement
•Extracellular metabolites
•Isotopomer intracellular 
metabolites
Perturbation
•Genetic modification
•Substrate feed
•Culture conditions
Analysis
•Metabolic flux analysis
•Flux control evaluation
 
Figure 2-1: Approach of Forward Metabolic Engineering.  
Metabolic engineering is an information-driven approach to phenotype improvement 
that involves (1) measurement, (2) analysis, and (3) perturbation.  Data from measurements can 
be used to formulate models.  These models can then be analyzed to generate new targets for 
manipulation (hypotheses).  After performing the genetic manipulations, experiments must be 
formulated to determine how the metabolic network has adjusted to each genetic manipulation.  
The cycle can then continue, providing more information with each round. 
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Microarrays have been developed, and new proteomic tools are 
evolving to monitor the response of gene expression to different 
perturbations (Bro, Regenberg et al. 2003; Ong and Mann 2005).   
Finally, to complete the cycle before proceeding to the 
next iteration, robust analyses are necessary to determine which 
portions of the network are the most sensitive or amenable to 
genetic manipulation and generate meaningful hypotheses from the 
vast quantities of data that can be gathered. By analyzing the 
differences in the metabolic fluxes following a perturbation, 
new targets can be identified that are most likely to improve 
the phenotype.  The new targets set the foundation for 
hypotheses, leading to another perturbation of the network.  
Such perturbations are followed by another round of measurement 
and analysis and may include: increasing the activity of 
desirable enzymes within a pathway either by overexpression or 
deregulation, deleting enzymes that divert carbon to undesired 
by-products, using different substrates, or changing the overall 
state of the cell to favor certain pathways.   
2.2. Inverse Metabolic Engineering (IME) 
When engineering cellular phenotypes such as product 
formation, substrate utilization, product tolerance, etc., 
rational approaches to genetic modification can be limited by 
the prior knowledge of the system.  While many metabolic 
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pathways have been identified or predicted by comparative 
genomics, missing regulatory information can limit how far the 
organism can be reprogrammed.  As well, knowledge of the 
metabolic pathways does not reveal the concentrations of 
intermediates and products of a pathway, or at what threshold 
concentrations these molecules will begin to have toxic effects 
on the cell.  Sometimes combinatorial or evolutionary approaches 
can be effective in eliciting these desired phenotypes by making 
perturbations that would not be considered in a rational 
approach (Santos and Stephanopoulos 2008).   
Inverse metabolic engineering is a combinatorial approach 
to identifying genotypes that elicit desired phenotypes (Bailey, 
Sburlati et al. 1996).  As mentioned, CSI approaches use 
chemical mutagenesis which can cause many mutations throughout 
the genome.  After screening for improved mutants, some of these 
mutations can be beneficial and some detrimental, and most often 
it is very difficult to locate the mutations.  IME 
differentiates itself from CSI approaches by using methods that 
introduce one genetic change at a time that can be readily 
identified in the clone.  Identifying the location and nature of 
the genotype can be very advantageous for further engineering 
the phenotype.  Even if the exact mechanism is not apparent, by 
identifying the genetic locus, further hypothesis-driven 
experiments can uncover the mechanism, as well as further 
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improve the desired phenotype by more refined changes around the 
genetic perturbation.  An additional advantage to this approach 
is it allows screening to be done in easy-to-work-with lab 
strains, while analogous directed genetic changes can be made in 
other organisms, where such screening would be impossible.   
IME has been successfully used recently in several systems.  
Jin has successfully used IME to identify genetic loci that are 
relevant in lycopene production by overexpressing random gene 
fragments from an E. coli library.  By doing this, he confirmed 
targets that were already known in the isoprenoid pathway, as 
well as new genes of unknown function.  Lycopene production was 
increased by X% (Jin and Stephanopoulos 2007).  Jin also used a 
combinatorial IME approach to optimize the levels of XYLA, XYLB, 
and XYLC in a recombinant pathway, toward improving xylose 
metabolism and ethanol production in Saccromyces cerevisiae, 
while reducing the byproduct xylitol, which had been a 
consistent problem in this area (Jin, Alper et al. 2005).    
(Weikert, Canonaco et al. 2000; Gill 2003; Sauer and Schlattner 
2004).  
The IME strategy involves three steps of perturbation, 
selection/screening, and genotype characterization.  
Perturbation is generating a library of mutants with different 
genotypes.  The type of genetic variation that can be introduced 
includes: single gene mutagenesis carried on a plasmid, 
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transposon insertion mutagenesis, plasmid library overexpression, 
and others.  An important aspect of the perturbation is that the 
genetic change can be easily characterized in the mutant.  This 
allows for routine identification of the genetic changes in 
mutants that show improved phenotype.  Step two employs an 
effective selection or high throughput screen to isolate mutants 
exhibiting desired phenotypes from the library.  Cells can be 
grown under a selection pressure that favors mutants with 
improved phenotype of interest.  If growth selection can not be 
used, as is often true when it is desired to increase the 
product, single cell measurement or microtiter plate screening 
can be employed for screening of desired mutants.  In step three, 
the mutants that have been isolated by screening as being of 
interest are characterized, and the genotypes underlying the 
desired behaviors of the selected cells are determined. 
2.3. Synergies between FME and IME 
IME is a natural complement to the approaches of forward 
metabolic engineering, and some natural synergies exist between 
the two approaches.  Forward metabolic engineering is an 
approach that utilizes existing information about the cell in a 
holistic, model-driven approach.  Existing data is integrated to 
create hypothesizes that will improve production characteristics.  
It requires fewer experimental methods than IME by virtue of 
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prior data minimizes the number of hypotheses that need to be 
evaluated.  However, forward approaches are limited by the 
available prior data.  These gaps in information will eventually 
limit the improvements that can be made by forward approaches.  
At this point, IME strategies can uncover new mechanisms that 
effect product accumulation in a methodical way.  These new 
mechanisms not only improve the productivity in their own right, 
most importantly, they add knowledge about the system.  This 
knowledge can be fed back to improve forward metabolic 
engineering models.  This can, and in most circumstances must, 
proceed iteratively due to the non-linear effects of many 
cellular perturbations. 
2.4. Polyhydroxybutyrate 
Poly-3-hydroxybutyrate (PHB) is a biopolymer from a class 
of naturally occurring polyesters called polyhyroxyalkanoates 
(PHAs) (Figure 2-2(a)).   Figure 2-2(b) shows the structural 
unit of PHB.  PHB has been studied extensively and is produced 
commercially on a small scale in bacteria (Kennedy 2007).  The 
polymer is easily biodegraded by a variety of bacteria that can 
depolymerize it for use as a carbon source (Anderson and Dawes 
1990).   
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Material properties 
PHB is a white crystalline polymer and can vary in 
molecular weight from 50,000 to 1,000,000 Da.  It is a straight 
chain monomer of 3-hydroxybutyrate.  PHB exists amorphously in 
the bacterial cell, but becomes highly crystalline, and 
therefore brittle upon extraction (Madison and Huisman 1999).   
Copolymers of 3-hydroxybutyrate and 3-hydroxyvalerate have shown 
to be less brittle and have properties similar to polyethylene 
and polypropylene in thermoplastic applications.  Table 2-1 
shows a comparison of material properties of PHAs to 
polypropylene. 
(a)              (b)  
Figure 2-2: Structure of polyhydroxyalkanoates. 
(a) Structure of a general poly-3-hydroxyalkanoate.  R position can be substituted with 
many possible groups.  4-hydroxy- and 5-hydroxyalkanoates have also been observed.  (b) 
Structure of poly-3-hydroxybutyrate.  This is the most abundant and most studied PHA. 
R 
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Applications 
PHB is a biodegradable thermoplastic with the majority of 
applications being to replace current petrochemical polymers.  
From an ecology standpoint, PHAs offer two advantages over 
traditional plastics.  PHB is biodegradeable, in that many 
microorganisms are able to depolymerize PHB in the environment 
to recover the carbon on the order of months to years 
(Jendrossek, Schirmer et al. 1996).  (It is important to note 
that for commercial applications, PHB is not biodegraded in more 
sterile environments such as houses and offices.)  Also, PHB is 
made from renewable resources, typically carbohydrates or fatty 
acids.  These are in contrast to our current bulk plastics which 
will persist for long times and are synthesized from petroleum 
feedstocks.   
Table 2-1.  Properties of PHAs and polypropylene 
Value for*: 
Parameter 
P(3HB) P(3HB-3HV) P(3HB-4HB) P(3HO-3HH) Polypropylene 
Tm (
o
C) 177 145 150 61 176 
Tg (
o
C) 2 -1 -7 -36 -10 
Crystallinity (%) 70 56 45 30 60 
Extension to break (%) 5 50 444 300 400 
*Data from (Madison and Huisman 1999) 
Tm - melting temperature, Tg - glass transition temperature, P(3HB) is poly(3-
hydroxybutyrate), P(3HB-3HV) is poly(3-hydroxybutyrate-co-3-hydroxyvalerate) 
containing 20% 3HV, P(3HB-4HB) is poly(3-hydroxybutyrate-co-4-hydroxybutyrate) 
containing 16% 4HB, P(3HO-3HH) is poly(3-hydroxyoctanoate-co-3-hydroxyhexanoate) 
containing 11% 3HH. 
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For this reason industrial fermentation of PHB has been the 
focus of a number of studies (Abe, Taima et al. 1990; de Koning, 
Bilsen et al. 1994; de Koning, Kellerhals et al. 1997), while 
other studies have been directed towards the use of PHB-
producing organisms in the breakdown of wastewater (Doi 1990; 
Curley, Hazer et al. 1996), just to name a few.  (Engineering 
strategies will be discussed later.) 
PHB has been used in molding applications such as bottles, 
cosmetic containers, golf tees, and pens (Baptist 1963; Baptist 
1963; Webb 1990).  Polyvinyl alcohol/PHB blends can be extruded 
as sheets, for plastic film applications (Holmes 1986).  High 
value applications of PHB are uses as biomaterials for the 
medical industry, such as absorbable surgical suture, prosthesis 
or tissue engineering material (Williams SF, Martin DP et al. 
1999) and use in controlled drug release (Steinbüchel and 
Füchtenbusch 1998). 
Biological occurrence 
PHB is produced naturally by a variety of organisms.  
Bacteria including Ralstonia eutropha, Methylobacterium, 
Pseudonomas alcaligenes latus, and Azobacter vinelandii have 
been reported to produce PHB (Madison and Huisman 1999).  R. 
eutropha has been the most extensively studied native PHB 
producer and has been examined for use in industrial production.  
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The biological function of PHB is as a carbon and electron sink 
when there is a nutrient imbalance and nitrogen or phosphate is 
scarce.  There are many advantages for the organism to 
polymerize the excess carbon.  The insoluble PHB granules can be 
stored at high concentrations (up to 90% dry cell weight), does 
not affect the osmotic state of the liquid phase, and does not 
leak out.  When other nutrients become available, the PHB 
granules can be depolymerized and the carbon/reducing 
equivalents are recovered (Anderson and Dawes 1990).   
PHB metabolic pathway 
The genes for the PHB pathway have been identified and been 
expressed in Escherichia coli (Peoples and Sinskey 1989; Peoples 
and Sinskey 1989).  PHB is produced by a 3 step pathway from the 
central carbon metabolic intermediate, acetyl-CoA, and the 
reducing equivalent, NADPH (Figure 2-3).  The first step is the 
condensation of two acetyl-CoA moieties to acetoacetyl-CoA with 
the release of a CoA.  This step is catalyzed by β-ketothiolase 
(phaA) and is believed to be near equilibrium in most organisms 
(Masamune, Walsh et al. 1989).  The equilibrium favors the two 
acetyl-CoA molecules, but under PHB producing conditions 
depletion of acetoacetyl-CoA causes a thermodynamic shift 
allowing the reaction to proceed from acetyl-CoA to acetoacetyl-
CoA.  The second step is the NADPH-dependent reduction of 
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acetoacetyl-CoA to the monomer 3-hydroxybutyryl-CoA by the 
acetoacetyl-CoA reductase, phaB.  The availability of NADPH 
reducing equivalents are therefore necessary to drive the 
pathway forward.  Finally, the 3-hydroxybutyryl-CoA is 
polymerized to PHB by the PHB synthase, which can either be a 
one or two subunit protein depending on the organism.  The 
synthase typically sits on the cytosolic/PHB interface and 
extends the polymer chain by adding 3-hydoxybutyrate molecules 
to the end of the growing PHB chain after releasing the CoA.  In 
the systems explored in this thesis, only two component 
synthases (phaEC) were involved in the pathway. 
 
Figure 2-3: PHB metabolic pathway.  
The PHB metabolic pathway starts at the common precursor acetyl-CoA.  Acetyl-CoA and a 
reducing equivalent are consumed in the pathway, and PHB and 2 CoA’s are released.   Top 
level – genes involved in the pathway.  Second level – enzymes, Third Level – metabolites. 
Vertical arrows show the enzyme that is coded by the gene, or the reaction that is catalyzed by 
the enzyme.  Horizontal and curved arrows connect the metabolites involved in each reaction. 
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Several other proteins play roles in the depolymerization 
and regulation of PHB.  phaZ is the depolymerase responsible for 
breaking down PHB granules into shorter, soluble polymers from 
the PHB granule and an oligomer hydrolase converts the short 
chain PHB to (R)-(-)-hydroxybutyric acid which can be further 
metabolized by the cell (Huisman, Wonink et al. 1991). PHB 
levels are regulated to manage the nutrient resources that are 
available to a cell at a given time.  Specifically, if the cell 
is growing in a carbon rich medium that is lacking in other 
necessary elements (nitrogen, phophorus, oxygen, etc.), the 
pathway can be upregulated.  phaP acts as to regulate the size 
and number of PHB granules (Wieczorek, Pries et al. 1995).  phaP 
binds at the interface of the PHB granule and the cytoplasm, and 
the concentration of phaP in the cell is inversely proportional 
to the number of granules in a cell.  phaR is a regulatory 
protein that reduces phaP levels, presumably to manage granule 
size and number (York, Stubbe et al. 2002).  The levels of the 
polymerase (phaEC) have been shown to affect the molecular 
weight of the polymer (Sim, Snell et al. 1997).  Sim et. al. 
showed that overexpression of the phaC gene resulted in shorter 
chain length PHB, consistent with the hypothesis that a small 
number of polymerases will generate a few long chain length PHB, 
while many polymerases will generate lots of short chain length 
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PHB.  A model for PHB granule formation is presented by Madison 
and Huisman that is helpful, but beyond the scope of this review 
(Madison and Huisman 1999). 
Plants such as Arabidopsis thaliana, Gossypium hirsutum 
(cotton), and Zea mays(corn) have been engineered to make PHB 
(Madison and Huisman 1999). 
2.5. Previous metabolic engineering 
As there is a large opportunity for PHAs to make in-roads 
to the commodity polymers markets, much effort has been 
undertaken to better characterize and improve PHB production.  
While the molecular weight of the polymer is very important in 
affecting the material properties of the polymer, in this review 
we will focus only on efforts to increase yield, titer, and 
productivity, the traditional objectives of metabolic 
engineering.  Additionally, we will focus on the engineering 
studies in recombinant E. coli and Synechocystis in this review. 
Recombinant Escherichia coli 
Following the expression of the PHB biosynthetic pathway 
from R. eutrophus into E. coli (Schubert, Steinbüchel et al. 
1988; Peoples and Sinskey 1989), much work has taken place to 
improve the production in this system.  The overall PHB reaction 
from glucose is shown in Equation 2-1.  Two carbon atoms are 
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lossed as two pyruvates are converted to two acetyl-CoAs in the 
biochemical pathway.  Three reducing equivalents are also 
produced, and must be oxidized elsewhere (shown as H2).  A 
maximum theoretical yield of 0.48 g-PHB/g-glucose can be 
achieved.   
 
The route in which glucose is metabolized to PHB can vary.  
Equation 2-2, Equation 2-3, and Equation 2-4 below are different 
routes to pyruvate, an immediate precursor to the acetyl-CoA 
used for PHB synthesis, that give different forms of reducing 
equivalents and energy.  Figure 2-4 shows the final conversion 
from pyruvate to acetyl-CoA and some of the major pathways that 
compete with PHB synthesis for acetyl-CoA. 
 
 
Equation 2-1: Chemical conversion of glucose to PHB 
 
( ) 222646126 32 HCOOHCOHC n ++→  
Equation 2-2: Embden-Meyerhof-Parnas pathway (glycolysis) 
 
ATPNADHPyruvateADPHNADGlucose 222222 ++→+++ ++  
Equation 2-3: Pentose phosphate pathway 
 
ATPNADPHNADHCOPyruvateADPHNADPNADGlucose
3
5
2
3
5
3
5
3
5
3
11
2
3
5
2 ++++→++++
+++  
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There are differing views in the literature as to which 
molecules limit production of PHB in E. coli (discussed below). 
Acetyl-CoA and NADPH are required for the biosynthetic pathway, 
and adequate amounts of CoA and NADP+ are needed to allow for 
turnover in the pathway.  Aside from the metabolites in the 
pathway, the three enzymes must have enough activity to provide 
high flux to PHB and Km values that allow the enzymes to compete 
with other pathways for acetyl-CoA and NADPH.   
Equation 2-4 Entner-Doudoroff pathway 
 
ATPNADPHNADHPyruvateADPHNADPNADGlucose +++→++++ +++ 22  
Pyruvate
2 [Acetyl-CoA]
TCA Cycle
Poly-3-hydroxybutyrate
Acetyl-P Acetate
Fatty Acids
 
Figure 2-4: Metabolic pathways at acetyl-CoA node. 
Acetyl-CoA is a two carbon precursor for biomass creation and energy pathways.  It is 
primarily fed from the conversion of pyruvate, a glycolysis terminal product.  Fatty acids and 
various TCA cycle intermediates are used as building blocks for biomass, and acetate 
production and TCA cycle are used to create ATP under anaerobic and aerobic production, 
respectively.  Diversion of acetyl-CoA to PHB must be high, but carefully balanced to allow 
other necessary cellular functions to proceed.  Arrows represent metabolic pathways. 
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Additional considerations must be made for the effects of 
PHB granules in the cytoplasm.  Physical limitations must exist 
for the amount of PHB the cytoplasm can hold.  By way of being 
solid phase, PHB avoids many of the toxic effects that can be 
experienced by soluble products, allowing for high titers, but 
eventually the bulky granules will affect cellular processes.   
Genetic background choice has improved the physiology of E. 
coli and the genetic stability to improve PHB production.  By 
testing many backgrounds of E. coli for their accumulation of 
PHB, it was observed that cloning/expression strains such as XL-
1 Blue and E. coli wild type B accumulated more PHB than other 
cloning and wild type strains (Lee, Lee et al. 1994).  Biomass 
growth and expression of the PHB pathway was better in XL-1 and 
B compared to other strains examined.  The authors did note 
large amounts of filamentous E. coli in both the XL-1 and B 
strains.  FtsZ, a cell division protein, mitigates filamentation 
that can lead to biofilm growth when overexpressed (Wang and Lee 
1997).  The biofilms limited growth properties of the cells and 
nutrient uptake.  By overexpressing ftsZ, PHB titer was 
increased 6 fold.   
An additional problem occurs with plasmids, that limits PHB 
formation.  High copy number plasmids are required for 
substantial PHB formation, but under growth conditions, only a 
few copies of the plasmid are necessary to provide antibiotic 
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resistance or prevent cell death by parB (Lee, Chang et al. 
1994).  One group attempted to correct for this by designing a 
plasmid that suppresses copy number at low temperature (30oC) and 
induces plasmid replication at high temperature (38oC) (Kidwell, 
Valentin et al. 1995).  Using this “temperature switch,” the 
copy can be kept low during the beginning of production, and 
switch to high copy (and therefore high expression of the PHB 
pathway) once the desired biomass has been established. 
In silico models of PHB metabolism 
PHB synthesis has been modeled from both a kinetic-based 
model of the pathway from acetyl-CoA to PHB as well as large 
scale stoichiometric model that predict the effect on central 
carbon metabolism.   A kinetic model of the pathway for E. coli 
was derived from a model for A. eutrophus (van Wegen, Lee et al. 
2001).  This model predicted that the flux to PHB is most 
sensitive to the acetyl-CoA supply, and not the NADPH 
availability.  It also predicted that the activity of the NADPH-
dependent reductase may control the flux of the pathway.  A 
larger stoichiometric model was used to identify the importance 
of the Entner-Doudoroff (ED) pathway in PHB production and was 
validated experimentally by observing a decrease in PHB 
production after deactivating the 3-deoxy-6-phosphogluconate 
aldolase (eda) enzyme (Hong, Park et al. 2003).  The ED pathway 
provides one NAPDH that is required for PHB synthesis, unlike 
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glycolysis, which only creates NADH, and the pentose phosphate 
pathway, which creates two NADPH.   
NADPH studies have focused on altering the redox balance in 
the cell through (a) phosphoglucose isomerase (pgi) deletion, 
(b) overexpression of pentose phosphate (PP) pathway enzymes 
(zwf, gnd, talA, and tktA), (c) gluconate feeding, or (d) 
transhydrogenase overexpression (Shi, Nikawa et al. 1999; Lim, 
Jung et al. 2002; Jung, Lee et al. 2004; Sanchez, Andrews et al. 
2006; Song, Kim et al. 2006).  These act through [A] preventing 
glucose from being metabolized through the Embden-Meyerhof-
Parnas (EMP) pathway, and instead metabolized through the PP 
pathway or the Entner-Doudoroff (ED) pathway, making NADPH 
instead of NADH, [B] increasing activity of PP pathway causing 
NADPH Limitation vs Acetyl CoA limitation 
The literature offers conflicting viewpoints as to what 
limits PHB productivity.  Some have implicated NADPH as a 
limiting reagent under growth conditions, while others have 
ascerted acetyl-CoA limits productivity.  Because these studies 
have focused on broad changes in the cell, although PHB 
accumulation has increased, it becomes difficult to determine 
what mechanisms the perturbations are acting.  Additionally, 
some studies suffer from extremely poor growth rates, implying 
that PHB accumulation may still be in highly suboptimal 
conditions. 
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the same redirection as [A], [C] feeding substrates naturally 
metabolized by the PP or ED pathways, and [D] catalyzing the 
exchange of electrons from NADH to NADPH.  While these studies 
did change the availability of NADPH, it is unclear whether the 
observed increases in flux to PHB were a result of increased 
NADPH to drive the acetoacetyl-CoA reductase (AAR) reaction or 
altered regulation of the acetyl-CoA consuming reactions, making 
more acetyl-CoA available for PHB biosynthesis.    TCA cycle 
consumption of acetyl-CoA is linked to redox in the cell through 
product inhibition by NADPH of isocitrate dehydrogenase (Dean 
and Koshland Jr 1993), and allosteric inhibition by high 
NADPH/NADP+ ratios that have been associated with lowered 
citrate synthase activity for growth on glucose (Lee, Kim et al. 
1996; Lim, Jung et al. 2002).  For PHB production on glucose, 
measurements of  NADPH/NADP+ ratio was 3 and NADPH 
concentrations were 225 µM (van Wegen, Lee et al. 2001).  This 
is higher than the NADPH Km of AAR, 19 µM (Steinbuchel and 
Schlegel 1991), which should be sufficient to supply NADPH.  
Hong et. al. has shown that the ED pathway is used to provide 
NADPH for AAR in PHB production (unlike the EMP pathway which 
produces NADH) (Hong, Park et al. 2003).   
Acetyl-CoA limitations may also be more complicated than 
expected.  Acetate secretion is observed in PHB producing E. 
coli under aerobic conditions (Sanchez, Andrews et al. 2006), 
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implying an excess of acetyl-CoA is available.  Phosphate 
acetyltransferase (pta) and acetate kinase (ack) deletions, 
which should decrease acetate production, have decreased PHB 
accumulation, implying that enzyme competition for the acetyl-
CoA pool may not be the determining factor (Shi, Nikawa et al. 
1999).  Instead, the presence of acetyl phosphate may be 
required in order to activate the PHB synthase (Miyake, 
Schnackenberg et al. 2000) and without acetyl phosphate (the 
result of pta and ack knockouts) the PHB pathway may be down 
regulated.  The Shi study also showed that the addition of α-
methyl-glucoside, a glucose analog that retards glucose uptake 
through non-toxic competitive inhibition, decreases acid 
secretion, but does not change PHB accumulation.  PHB 
productivity appears to be insensitive to glucose uptake, 
implying the pathway may exert metabolic control over the flux 
from acetyl-CoA to PHB. 
A difficulty arises from comparing PHB studies that were 
based on a rich media, such as LB where a lot of carbon and 
organic nitrogen are available to the cell and do not need to be 
synthesized, compared to a minimal media where all biomass 
constituents must be derived from glucose and inorganic nitrogen.  
This will most certainly affect the NADPH required for 
catabolism of cellular components, and the carbon flux around 
and through acetyl-CoA.  These fundamental differences in 
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metabolism between rich and minimal media may have different 
limitations in PHB formation. 
The studies thus far have failed to look at the systemic 
changes that are induced by the perturbations to the system and 
have instead focused on perturbations that will have pleitropic 
changes.  The redox state of the cell has far reaching effects 
on the metabolic network, and increases observed in PHB 
production may be due to regulatory effects that divert acetyl-
CoA toward PHB rather than TCA cycle.  It is important to 
observe the metabolic network as a whole, and make perturbations 
that are localized to determine the actual mechanisms of 
increased PHB accumulation.  
Synechocystis PCC 6803 
Synechocystis is a model organism for studying 
photosynthesis because it contains both photosystem 1 and 2 
found in higher plants, but has the experimental convenience of 
being a fast growing, unicellular cyanobacteria.  The 
Synechocystis genome sequence was published in 1996 (Kaneko, 
Sato et al. 1996) and genetic tools have been used to 
characterize the photosynthetic processes in the cell (Vermaas, 
Williams et al. 1987).  This allows modern functional genomics 
approaches to be available for the organism. 
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PHB production in Synechocystis has been explored (Hein, 
Tran et al. 1998; Taroncher-Oldenberg, Nishina et al. 2000; 
Taroncher-Oldenburg and Stephanopoulos 2000; Sudesh, Taguchi et 
al. 2002; Wu, Shen et al. 2002).  Synechocystis can use carbon 
dioxide and light as raw materials and can both carry out 
photosynthesis and convert sequestered carbon dioxide to PHB, 
eliminating the need for a second organism to do photosynthesis 
to provide sugars or fatty acids, which is required for other 
PHB fermentation processes. This Synechocystis one-step process 
could be achieved in both plants and microbial photosynthetic 
organisms (Madison and Huisman 1999).  Synechocystis is thus an 
amenable organism for studying PHB production in the context of 
photosynthetic organisms, both as itself and as a model for PHB 
production in higher plants.   
Physiological and biochemical aspects of PHB have been 
determined.  The three enzymes for synthesizing PHB from acetyl-
CoA have been identified in Synechocystis (Taroncher-Oldenberg, 
Nishina et al. 2000; Taroncher-Oldenburg and Stephanopoulos 
2000).  The pathway is primarily active when there are nutrient 
limitations (nitrogen or phosphate), but available carbon 
sources or reducing equivalents.  The biochemical and genetic 
regulation of the PHB pathway has not been elucidated in the 
open literature. 
 50 
PHB production has been altered both by nutrient feeding 
strategies and genetic alterations. While Synechocystis produces 
PHB at 1% dry cell weight (DCW) in BG11, a balanced nutrient 
broth for photosynthetic organisms, under low phosphate and low 
nitrogen conditions it has been shown to accumulate up to 7% DCW 
in wild-type Synechocystis (Sudesh, Taguchi et al. 2002; Wu, 
Shen et al. 2002).  Supplementation with acetate has been 
observed to increase PHB accumulation, although it has not been 
determined whether it acts as an extra substrate for PHB or in a 
regulatory mode (Sudesh, Taguchi et al. 2002). Overexpression of 
the Type III PHB synthase was carried out, but did not increase 
PHB yield (Sudesh, Taguchi et al. 2002), implying that enzyme-
level regulation and/or another step in the pathway limits flux 
to PHB.  Wu et. al. deleted the ADP-glucose pyrophosphorylase to 
prevent Synechocystis from accumulating glycogen (Wu, Shen et al. 
2002).  In glycogen deficient strains of Synechocystis, 17% DCW 
PHB has been reported; the highest reported accumulation of PHB.  
Synechococcus, while a natural PHB producer, was engineered with 
the heterologous PHB pathway from R. eutropha, and accumulated 
PHB up to 25% DCW, the highest PHB accumulation observed for 
cyanobacteria (Takahashi, Miyake et al. 1998).  It is likely 
that the recombinant expression avoided regulatory mechanisms 
that limit PHB production by the native pathway.   
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It is not understood what genetic/biochemical mechanisms 
are used to turn on or off PHB production in the different 
nutrient starvation conditions. Direct genetic control of PHB 
production may be advantageous to achieve high levels of PHB 
under optimal growth conditions, eliminating the need for 
nutrient starvation for commercial scale production. IME 
strategies will be useful in identifying how genetic control of 
PHB production is achieved in the cell. 
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3 Development of a high-throughput screen for PHB 
3.1. Nile red fluorescence screen for PHB 
3.1.1. Introduction 
Combinatorial approaches do not require much prior 
knowledge, but instead rely on methods for the rapid assessment 
of the phenotypes of a diverse mutant library to identify clones 
with improved properties.  Inverse metabolic engineering (IME) 
(Bailey, Shurlati et al. 1996; Jin, Alper et al. 2005) embodies 
the essence of the combinatorial approach, comprised of 
generating genomic perturbations, such as gene knockouts and 
over-expressions, and then screening them for the desired 
phenotype.  High scoring clones are then isolated, and the 
genomic perturbation is identified.  Many genomic perturbations 
have been developed based on transposons, plasmid overexpression, 
gene shuffling and other random mutagenesis methods (Alper, Jin 
et al. 2005; Alper, Miyaoku et al. 2005).  An integral component 
of combinatorial approaches is a high throughput screen for 
efficiently probing the library diversity.  Towards this end, a 
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high throughput screen for measuring intracellular PHB was 
designed for the two organisms, Synechocystis and Escherichia 
coli.  The screen must be have enough capacity to measure 105 
mutants with the precision and accuracy to discern differences 
in PHB on the order of 5% PHB (DCW). 
Prior PHB screening methods used nile red a dye that stains 
PHB and other neutral lipids in bacteria (Ostle and Holt 1982). 
These staining methods can be classified into two categories: 
(1) non-lethal and qualitative, and (2) lethal and quantitative.  
Nile red staining protocols that keep cells viable have only 
been able to differentiate non-PHB producing from PHB producing 
cells (Spiekermann, Rehm et al. 1999).  Presumably, this is due 
to inefficient membrane permeability of nile red in living cells.  
While this is helpful for identifying organisms that make PHB, 
it lacks the sensitivity necessary to detect incremental 
improvements one might expect in an engineered strain over a 
parental strain.  Prior quantitative assessments of PHB based on 
nile red fluorescence have involved various fixing steps 
(Degelau, Scheper et al. 1995; Müller, Lösche et al. 1995; 
Gorenflo, Steinbuchel et al. 1999; James, Mauchline et al. 1999; 
Vidal-Mas, Resina-Pelfort et al. 2001).  The fixing step, 
typically executed with an alcohol or acetone treatment, 
facilitates the permeation of the dye through the membrane.  
While this allows for accurate detection of PHB levels, the 
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lethal nature of the protocol prevents its use in a screen for 
detecting mutants with improved PHB accumulation. 
A staining protocol that can accurately measure PHB content 
in a combinatorial screen must allow the stain to enter the cell, 
specifically stain granules, and maintain high viability.  Dye 
binding specificity (and the resulting fluorescence intensity) 
is a thermodynamic property and a function of the staining 
conditions (temperature, ionic strength, etc).  Cell 
permeabilization methods have been developed for other 
applications, such as extracting proteins from the outer 
membrane (Vazquez-Laslop, Lee et al. 2001) or transforming 
bacteria with plasmids (Sambrook, Fritsch et al. 1989).  
Adapting such methods to transport nile red across the membrane 
could allow efficient staining of the PHB granules.  In this 
chapter, we describe the development of two novel methods for 
detecting PHB based on nile red fluorescence that is both 
quantitative and maintains cell viability.  Each protocol can 
distinguish incremental differences in PHB appropriate for 
library screening in E. coli or Synechocystis. 
3.1.2. Materials and methods 
Bacterial strains and growth medium 
Synechocystis PCC 6803 was grown at 30ºC in BG11 medium 
(Rippka, Deruelles et al. 1979).  Cultures were grown in a 
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light-tight incubator (E-36, Percival Scientific, Boone, Iowa) 
at 100 µmol of photons m-2 s-1 provided by cool white fluorescent 
lightbulbs. Cultures containing different amounts of PHB were 
prepared by growing them in BG11(P), a modified BG11 medium with 
0.018 mM K2HPO4 (10% of the concentration in BG11), and/or 
supplementing with 10 mM acetate for 8-12 days.  Cells were 
cultured in Erlenmeyer flasks on a rotary shaker.  A 0% PHB DCW 
control strain was made using a PHB synthase knockout, phaECsyn
- 
(Taroncher-Oldenburg and Stephanopoulos 2000).   
E.  coli (XL-1 Blue, Stratagene, La Jolla, Calif.) 
transformed with a modified pJOE7 (Lawrence, Choi et al. 2005) 
plasmid was cultured at 37ºC in Luria-Bertani (LB) medium 
containing 20 g/L glucose and 25 µg/mL kanamycin.  The modified 
pJOE7, called pAGL20, was kindly provided by Dr. Anthony Sinskey 
and contains the gene phaAB from R. eutropha encoding the β-
ketothiolase and the acetoacetyl CoA reductase, phEC from 
Allochromatium vinosum encoding the two subunit PHB polymerase, 
and encodes kanamycin resistance.  As a no PHB control, the same 
plasmid without the pha genes was also cultured.  Optical 
density was used to track cell growth using an Ulstrapec 2100pro 
(Amersham Biosciences, Uppsala, Sweden).  Synechocystis and E. 
coli were tracked by absorbance at 730nm and 600 nm respectively. 
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Staining and fluorescence activated cell sorting (FACS) 
A nile red (Sigma-Aldrich, St. Louis, MO) stock solution 
was made by dissolving to 1 mg/mL in dimethyl sulfoxide (DMSO) 
unless otherwise noted.  3 µL of stock solution was added to 1 
mL of staining buffer as indicated in the staining optimization.  
FACS was carried out on a FACScan (Becton Dickinson, Mountain 
View, CA) using the following settings; Synechocystis FSC=E00, 
SSC=411, FL-1=582, FL-2=551 and E. coli FSC=E00, SSC=411, FL-
1=582, FL-2=535.  Cells were excited with an air-cooled argon 
ion laser (488 nm), and FL-2 (585nm) was used to detect nile red 
fluorescence.  Flow cytometry analysis was done on 50,000 cells 
using WinMDI 2.8.  
Staining effectiveness was characterized by resolution, RS 
(Equation 3-1), where Mn is the 
geometric mean of the fluorescence distribution of n (n=1 is the 
PHB producing cell, n=2 is the no PHB control).  δn is the 
standard deviation of the fluorescence distribution.  RS is a 
quantitative measure of the ability to differentiate two 
populations. 
Equation 3-1: Resolution equation 
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Cell viability was accessed by the ratio of the colony 
forming units (cfu) in the final stained preparation to cells 
from the media. 
Chemical PHB analysis 
PHB was analyzed as shown previously (Taroncher-Oldenburg 
and Stephanopoulos 2000).  >10 mg of cells was collected from 
culture by centrifugation (10 min, 3,200×g).  The resulting cell 
pellet was washed once with cold deionized water and dried 
overnight at 80°C. The dry cells were boiled in 1 ml of 
concentrated sulfuric acid for 60 min, then diluted with 4 ml of 
14 mM H2SO4.  Samples were centrifuged (15 min, 18,000×g) to 
remove cell debris, and liquid was analyzed by high pressure 
liquid chromatography using an Aminex HPX-87H ion-exclusion 
column (300 x 7.8 mm; Bio-Rad, Hercules, Calif.) (Karr, Waters 
et al. 1983).  Commercially available PHB (Sigma-Aldrich, St. 
Louis, Mo.), processed in parallel with the samples, was used as 
a standard. 
Synechocystis staining optimization 
Synechocystis WT and phaEsyn
- cultures were grown for 7 days 
to early stationary phase.  Dye concentration optimization: 
Cells were centrifuged (5 min, 3000×g), and resuspended to 
A730=0.4 in 0.9%(w/v) sodium chloride solution.  3 uL of 
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different concentration nile red solution was added to 1 mL of 
resuspended cells to final concentrations between 30 to 30,000 
ng/mL.  The mixture was incubated in the dark for 30 min and 
analyzed on the FACScan.  Staining conditions optimization: 
Deionized water and 0.9%(w/v) sodium chloride were used to 
resuspend the cells for staining to an A730= 0.4.  3 µL of 10 
mg/mL nile red in DMSO was added to 1 mL of resuspended cells.  
The mixture was incubated in the dark for 30 min and analyzed on 
the FACScan.  Destain buffer optimization: Staining was 
performed as above.  After staining, cells were centrifuged (5 
min, 3000×g), and resuspended to the same volume in:1%(w/v) 
sucrose, 1%(w/v) DMSO, phosphate-buffered saline (PBS), PBS + 
1%(w/v) DMSO, 0.9%(w/v) sodium chloride + 1%(w/v) DMSO, or 
deionized water.  Cells were incubated in the dark for 30 min 
and analyzed on the flow cytometer. 
E. coli staining optimization 
E. coli XL1-Blue harboring the modified pJOE and the no PHB 
control were cultured as described.  Shock optimization: 
Cultures were grown to stationary phase.  Sucrose shock, 
isopropanol treatment, dimethyl sulfoxide treatment, and heat 
shock permeabilization methods were tested for resolution and 
viability after the shock as follows.  Sucrose shock was carried 
out as shown previously (Vazquez-Laslop, Lee et al. 2001).  1 mL 
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of culture was cooled to 4ºC for 10 min.  The cells were then 
centrifuged (3 min, 3000×g, 4ºC) and resuspended in 1 mL ice-
cold TSE buffer (10 mM Tris-Cl [pH=7.5], 20%(w/v) sucrose, 2.5 
mM Na-EDTA).  The TSE mixture was incubated on ice for 10 min 
then resuspended (3 min, 3000×g, 4ºC) in 1 mL deionized water 
with 3µL 10 mg/mL nile red in DMSO.  The solution was incubated 
in the dark for 30 min and analyzed on the FACScan.  Isopropanol 
shocked cells were prepared by centrifuging (3 min, 3000×g) and 
resuspending in 70%(w/v) isopropanol for 15 min.  Cells were 
then centrifuged (3 min, 3000×g) and resuspended in deionized 
water with 3µL of 10mg/mL nile red in DMSO and incubated for 30 
min in the dark and analyzed on the FACScan.  DMSO shock was 
performed by centrifuging (3 min, 3000×g) 1mL of cell culture.  
50 µL of 10 mg/mL nile red in DMSO was added directly to the 
pellet.  The pellet was quickly vortexed and diluted to 1 mL in 
water after incubating for 30 s.  Cells were incubated for 30 
min in the dark and analyzed on the FACScan.  Heat shock was 
performed as in competent cell preparation (Sambrook, Fritsch et 
al. 1989).  1 mL of cells was cooled on ice for 10 min.  Cells 
were then centrifuged (3 min, 3000×g, 4ºC), and resuspended in 1 
mL cold 80mM MgCl2 / 20 mM CaCl2.  The sample was then 
centrifuged (3 min, 3000×g, 4ºC) and resuspended in 1 mL 0.1 M 
CaCl2 with 3µL of 10 mg/mL nile red in DMSO.  Cells were heat 
shocked at 42ºC for 90 s and incubated for 30 min in dark then 
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analyzed on the FACScan.  Concentration optimization:  Cells 
were prepared by sucrose shock using 3µL of different nile red 
solutions to a final concentration between 30 – 30,000 ng/mL.  
Sucrose concentration optimization: Cells were prepared by 
sucrose shock using TSE buffer with varying sucrose 
concentrations (0,5,10,15,20%(w/v)).  Nile red of 10 mg/mL in 
DMSO was used for staining. 
3.1.3. Results 
Synechocystis protocol development 
To maximize the resolution between PHB producing strains 
and controls in Synechocystis, nile red concentration and 
staining buffers were optimized to increase specific staining 
while minimizing non-specific staining.   A destain step was 
introduced and evaluated presuming it would remove nonspecific 
stain from the cells.  Figure 3-1(A) shows the effect of nile 
red concentration on resolution for Synechocystis.  3.3 µg/mL 
nile red was found to yield the best resolving power.  Nile 
red’s fluorescence intensity is a function of the ionic 
character of the solution.  Water and 0.9%(w/v) sodium chloride 
were examined as staining buffers to test the effect of solution 
ionic strength on nile red staining and fluorescence.  Water 
showed a much higher difference in cell staining compared to the 
sodium chloride solution (Figure 3-1(B)).  Several destaining 
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solutions were examined to attempt to reduce non-specific 
staining.  While the sodium chloride-based buffers performed 
worse than the non-ionic buffers, none of the destaining buffers 
significantly improved the resolution of the assay (data not 
shown). 
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Figure 3-1: Synechocystis protocol optimization. 
(A) Effect of nile red concentration on staining resolution; (B) Effect of buffer used for staining 
on resolution; RS is the resolution parameter (see text for definition) (all error bars represent 
standard deviation of duplicate experiments). 
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The optimized protocol is as follows:  The cells were 
harvested by centrifugation (5 min, 3000×g) and resuspended to 
A730=0.4 in deionized water.  Next, 3 µL of a 1 mg/mL nile red in 
DMSO stock solution was added to 1 mL of the cell suspension and 
incubated in the dark for 30 min.  Finally, the cells were 
immediately analyzed by flow cytometry. 
Following protocol optimization, cultures grown under 
different conditions were assayed by the nile red staining 
protocol and chemical PHB analysis.  As shown in Figure 3-2(A), 
the geometric mean of the flow cytometer measurement correlated 
very well with the analytical PHB measurements over a large 
dynamic range of PHB concentrations in different growth media.  
Comparison of the nile red fluorescence histogram for cells 
stained with 30 µg/mL nile red in 0.9 %(w/v) sodium chloride 
(Figure 3-2(B)) (protocol from (Gorenflo, Steinbüchel et al. 
1999)) and the optimized protocol (Figure 3-2(C)) demonstrated a 
significant improvement in the overall staining.  Non-specific 
staining in the overall population has been reduced by a 
shifting of the primary 0% PHB DCW peak to lower fluorescence, 
as well as a reduction of a secondary peak that was a result of 
strong non-specific staining. 
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Figure 3-2: PHB staining effectiveness for Synechocystis. 
(A) Correlation of fluorescence measurement from PHB staining protocol with chemical PHB 
measurement; (B) Histogram of 10% PHB DCW Synechocystis (gray) and 0% PHB DCW 
Synechocystis (black outline) using initial (low resolution) staining protocol; (C) Histogram of 
10% PHB DCW Synechocystis (gray) and 0% PHB DCW Synechocystis (black outline) using 
final optimized staining protocol (see text for details). 
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E. coli protocol development 
The optimized Synechocystis staining protocol was used as a 
starting point in investigating E. coli staining.  Very poor 
staining of PHB was observed with this protocol, even in 
stationary phase where PHB accumulates to a level of 
approximately 40% DCW.  Assuming that the observed staining 
differences are due to greater dye permeability through 
Synechocystis cell membranes, methods to improve the dye 
permeability of E. coli were examined.  Figure 3-3(A) shows the 
resolution achieved by different permeabilization methods on 
stationary phase E. coli cells.  Stationary phase E. coli was 
used to assure large differences in PHB.   Of these, sucrose 
shock permeabilization gave the best resolution between high and 
no PHB strains, albeit with a very low viability of 0.022%. 
To improve cell viability, the effect of varying the 
sucrose concentration used in the sucrose shock was studied.  
Exponential phase E. coli, which did not have as large a 
difference in PHB accumulation, was found to be more sensitive 
to the sucrose shock and was examined as a worst-case scenario 
for viability.  Figure 3-3(B) shows the trade off between higher 
viability and better staining.  Overall, a 10%(w/v) sucrose was 
found to yield similar staining characteristics to those 
obtained with higher sucrose concentration, while maintaining a 
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viability of 21%.  Nile red concentration was varied to optimize 
resolution.  A nile red concentration of 33 µg/mL gave the best 
separation of the peaks (Figure 3-3(C)).  This increase in 
optimal nile red concentration compared to Synechocystis is most 
likely due to increased amounts of PHB in E. coli.  
Concentrations above this level were not soluble in the stock 
solution and gave considerable noise in the measurement (data 
not shown).  Cell viability was not affected by nile red 
concentration (data not shown).   
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Figure 3-3: E. coli protocol optimization. 
(A) Effect of different osmotic shock protocols on staining [see Materials and Methods for 
details]; (B) Effect of sucrose concentration on staining resolution and cell viability [●] 
Resolution of PHB and no-PHB controls [□] Viability of PHB control; (C) Effect of nile red 
concentration on staining resolution. 
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To further improve the viability of the cells after the 
staining procedure, different resuspension buffers used after 
the TSE incubation step were evaluated.  Water, LB, and 1 mM 
magnesium chloride broth had a viability of 21%, 18%, and, 48% 
respectively.  While even with the magnesium chloride only half 
the population survived, this only doubled the number of cells 
that would needed to be sorted in order to screen a library. 
The optimized E. coli staining protocol is as follows: 
Cells were cooled to 4ºC, and then harvested by centrifuging (5 
min, 1000×g, 4ºC).  Next, cells were resuspended to A600=0.4 in 
10%(w/v) sucrose TSE buffer, and incubated on ice for 10 min.  
After this, the sample was centrifuged (5 min, 3000×g, 4ºC) and 
resuspended to the same volume in 4ºC 1 mM MgCl2.   This was 
followed by the addition of 3 µL of a 1 mg/mL nile red in DMSO 
to 1 mL of the cell suspension and incubated in the dark for 30 
min. Finally, the cell population was immediately analyzed by 
flow cytometry. 
Figure 3-4(A) shows the correlation between the PHB 
measurement obtained by the optimized E. coli nile red staining 
protocol and by chemical PHB analysis.  The data shown in Figure 
3-4(A) correspond to cells harvested at different time points 
along a growth curve over a broad range of PHB amounts from 
exponential to stationary phase.  Figure 3-4(B) and (C) show the 
dramatic improvement in staining achieved in the final protocol.  
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As indicated in Figure 3-4(B), a large portion of the population 
was not stained in the original protocol but was stained after 
introducing the sucrose shock step.  
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Figure 3-4: PHB staining effectiveness for E. coli. 
(A) Correlation of fluorescence measurement from PHB staining protocol with chemical PHB 
measurement; (B) Histogram of ~40% PHB DCW E. coli (gray) and 0% PHB DCW E. coli  
(black outline) using Synechocystis staining protocol; (C) Histogram of ~40% PHB  DCW E. 
coli (gray) and 0% PHB DCW E. coli  (black outline) using final optimized staining protocol 
(see text for details). 
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3.1.4. Discussion 
High resolution FACS experiments can sort cells from a 
population only to the extent that the fluorescence level of the 
cell correlates with the phenotype that is being examined.  When 
trying to develop a staining protocol that yields good 
correlation between fluorescence and, in this case, PHB levels, 
important factors are, (a) promoting specific fluorescent 
molecule binding to the target (PHB), and, (b) allowing adequate 
access of the fluorescent molecule to the target.   
In the nile red optimization for PHB fluorescence, molecule 
specificity was addressed by varying the environment for 
staining.  This was especially important in Synechocystis. 
Synechocystis has multiple layers of thylakoid membrane which is 
used in its photosynthetic apparatus.  These membranes provide a 
large area of lipid-like interfaces for non-specific binding of 
nile red.   To minimize binding of the nile red to the thylakoid 
membrane, ionic strength of the medium and dye concentration 
were examined.  Changing the ionic strength of the staining 
environment from a sodium chloride solution to deionized water, 
the nile red stained the PHB more specifically.  Additionally¸ 
the dye concentration also strongly affected the resolution of 
the assay.  In E. coli, this was not as important.  The effect 
of dye concentration increased, unlike in Synechocystis where a 
maximum was observed.  The ionic strength did not affect the 
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resolution in E. coli (data not shown).  These observations can 
be attributed to the lack of large membrane structures in E. 
coli. 
Providing consistent access of the fluorescent molecule to 
the target is also necessary for a quantitative fluorescence 
level.  In Synechocystis, the stain readily permeated the cell 
and stained the PHB granules.  Figure 3-2(B) shows that even in 
the prior staining protocol, all Synechocystis cells were being 
stained.  This should be contrasted with Figure 3-4(B) which 
shows that a large portion of the E. coli did not stain at all 
for PHB in the non-optimized protocol.  Synechocystis is a 
naturally competent cell, and as such is able to take up DNA 
molecules readily.  This may imply the morphology of 
Synechocystis’s membrane may allow it to take up nile red more 
readily than E. coli, which is not naturally competent.  To 
improve the dye transport across the E. coli cell membrane, 
competent cell protocols and other permeabilization methods were 
attempted.  Of these, sucrose shock permeabilized the cells in 
such a way that the nile red could enter the cytoplasm and stain 
the granule.   
While the E. coli cells could now take up the nile red, 
most of the cells were killed in the process.  Further 
optimization was required to increase the cell viability while 
retaining good staining properties.  Adjusting sucrose 
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concentration and the buffers used improved the viability to 48%.  
This will allow an adequate efficiency for screening mutant 
libraries by FACS. 
To validate the use of resolution (Eq. 1) as a metric for 
optimizing the protocol and to estimate the accuracy of the nile 
red fluorescence, the geometric mean of the fluorescence 
distribution was compared to a chemical PHB measurement of the 
culture.  As there is presently no validated method for 
measuring PHB levels at the individual cell level, population 
average measurements, geometric mean of fluorescence and the 
whole culture chemical PHB measurement, were required to assess 
the quantitative accuracy of the staining protocols. The 
correlation between fluorescence and PHB content were greatly 
improved from initial staining experiments (data not shown) due 
to the improved staining of PHB granules and reduction in non-
specific staining.  The estimated error of prediction of PHB 
content from the geometric mean of fluorescence was  ± 1.2% PHB 
DCW and ± 4.5% PHB DCW for Synechocystis and E. coli 
respectively (95% confidence of interval).  From this, it can be 
inferred that the PHB levels on the single cell level can be 
estimated accurately based on the fluorescence measurement.   
These protocols will allow single cell measurements of PHB 
levels in Synechocystis and E. coli to a precision that mutants 
with incrementally increased PHB accumulation can be sorted from 
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the library and characterized.  Using FACS, 10 million cells can 
easily be assayed in less than 1 hr.  While there will be a loss 
due to nonviable cells in the E. coli system, this loss does not 
prohibit the assay from screening genome scale libraries.  As 
well, multiple cells of the same genotype will be present due to 
growth, increasing the likelihood of each library variant being 
screened. 
Biological noise will most likely contribute false 
positives to the screen.  Inherent in all single cell 
measurements is the cell-to-cell variation even in a clonal 
population.  This is evident in Figure 3-2(C) and Figure 3-4(C).  
For the positive controls, a clonal population has a 10 fold 
difference in fluorescence within the population.  This 
variation in PHB content will result in false positives being 
sorted as high PHB clones, while their average PHB content may 
be less. 
The application of sucrose shock to allow E. coli to take 
up nile red is generalizeable to other bacteria and other small 
molecule dyes which do not permeate the membrane.  By using such 
permeabilzation methods to allow impermeable fluorescent dyes to 
enter the cytoplasm, the number of phenotypes that can be 
screened in a high throughput fashion can be significantly 
increased.  This will enable new fluorescence-based 
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combinatorial screens for other phenotypes where high throughput 
screens do not currently exist. 
3.2. Dielectrophoresis screen for PHB 
Besides the fluorescence of nile red, other approaches were 
initially investigated as means to sort cells based on PHB 
content, including dielectrophoresis, density gradient 
centrifugation, and momentum-based microfluidics.  Density 
gradient centrifugation and momentum-based microfluidics were an 
attempt to separate cells based on their density or weight/size.  
While PHB content did alter these parameters of a cell, many 
other factors also changed this, and these methods proved 
incapable of reliably isolating mutants with high PHB content.  
Dielectrophoresis was pursued extensively but in the end was not 
as effective as the nile red fluorescence screen.  
Dielectrophoresis field flow fractionation (DEP-FFF) is a 
chromatographic method for separating micron size particles by 
their electrical properties (Markx, Rousselet et al. 1997; 
Rousselet, Markx et al. 1998).  DEP-FFF uses an electric force, 
which is dependent on electric properties and geometry of the 
cell, to levitate cells to different heights in a parabolic flow 
field.  This microfluidic technique was explored as a possible 
screen for high PHB cells.  DEP-FFF sorts based on electrical 
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properties of the cell and could be used for screening other 
phenotypes that would change the cell’s electrical properties. 
The DEP force is a function of intracellular content and 
the extracellular medium.  The magnitude and direction of the 
DEP force is dependent on a variety of factors including the 
media conductivity, cytoplasmic conductivity, and the voltage, 
frequency, and geometry of the AC electric field (Gascoyne and 
Vykoukal 2002).  We hypothesized that the cytoplasmic 
conductivity of a cell is a strong function of the amount of 
polymer accumulated.  This is because the volume of PHB in the 
cell is nonconductive, and as this volume changes, so does the 
average conductivity of the cytoplasm.  In a given set of 
conditions, cells with high PHB might have a different DEP force 
than cells with little PHB.   
To test this hypothesis, we placed E. coli that were PHB+ 
or PHB-, as described above, consecutively on a quadrapole 
microelectronic microscope slide, overlaid with a solution 
containing the cells and 0.4 X phosphate-buffered saline.  A 
2.5V AC electric field was induced on the quadrapole.  Figure 
3-5 shows that PHB+ E. coli are attracted to electrodes when the 
AC field is at 1 MHz, while PHB- E. coli are not.  At higher 
frequencies, both cells are repelled from the electrodes.  The 
difference in forces was confirmation that DEP was affected by 
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PHB content, and could potentially be used for a separation of 
the two types of cells in a DEP-FFF device. 
 
Field flow fractionation takes advantage of these PHB-
dependent DEP forces.  Figure 3-6 gives a schematic 
representation of the device.  A sample loop is used to load 
cells into the front of the DEP-FFF chamber.  Flow is stopped, 
and the cells are allowed to settle to the bottom of the chamber.  
At this time, the signal generator is turned on, inducing the 
electric field.  The DEP force pushes the cells vertically away 
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Figure 3-5: Dielectrophoretic force of E. coli.   
Negative DEP forces pull PHB- cells to the electrodes at 1 MHz, but not PHB+ cells.  Neither 
cell is attracted at 80 MHz.  XL-1 Blue (pAGL20) [PHB+] and XL-1 Blue (pAGL19) [PHB-] 
were suspended in a 2 parts phosphate buffered saline (PBS) and 3 parts water.  A 2.5 V AC 
electric field was induced at 1 MHz and 80 MHz.  pAGL19 is the same backbone plasmid as 
pAGL20, without the PHB operon. 
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from the electrodes (see Figure 3-6 inset).  The strength of the 
DEP force decays with distance from the electrodes.  When the 
field is turned on, the cells equilibrate at a height where the 
DEP force and gravitational force are equal.  Since the 
magnitude of the DEP force is a function of the PHB content of 
the cells, the equilibrium height will be different for cells 
with different amounts of PHB.   
 
After the cells have reached their equilibrium height, 
buffer is pushed through the device.  The parabolic flow profile 
causes cells that are near the centerline to travel quickly 
through the device and cells near the bottom to travel slowly 
(all cells are well below the half height to avoid convolution 
do to the upper half of the parabola).  This causes high PHB 
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Figure 3-6:  Schematic representation of DEP-FFF. 
See text for description.  Upper left inset from Gascoyne and Vykoukal (2002).  
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cells to have a short residence time in the device and are 
collected in early fractions. 
Several parameters had to be defined in order to correctly 
separate cells based on PHB.  Geometric (flow chamber dimensions, 
electrode width and spacing) and operational (solution 
conductivity, voltage and frequency of AC field, fluid flow 
rate) parameters affect the ability to discriminate on PHB.  
While several of these parameters were adjusted to improve 
separation conditions in the DEP-FFF device, satisfactory 
separations were never achieved.  Although DEP force was a 
function of PHB accumulation, other cellular properties, such as 
viability, cell size, and culture age, affected DEP and 
convoluted the separation.  This was in contrast to nile red 
fluorescence, which was primarily a function of cellular PHB 
content.  DEP-FFF was at not as mature as FACS and would 
required significant further investigation to have a useful 
screen.  While currently this technology is not ready for mass 
use, further development promises significantly cheaper 
approaches to sorting, compared to the large capital costs of 
FACS machines. 
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4 Identification of gene disruptions for increased 
poly-3-hydroxybutyrate accumulation in Synechocystis 
PCC 6803 
4.1. Introduction 
Given that a high throughput screen has now been 
established, we turned our attention to identifying genetic 
nodes that increase PHB accumulation in Synechocystis.  Although 
all polyhydroxyalkanoates ultimately use carbon dioxide and 
light as a feedstock, Synechocystis offers a direct route, 
unlike heterotrophic bacteria, which would require cultivation 
of starches in plants, purification, and finally fermentation.  
A one step PHB synthesis process, whereby a single organism is 
employed to both carry out photosynthesis and convert 
sequestered carbon dioxide directly to PHB, would eliminate the 
current need for two organisms: (1) to carry out photosynthesis 
to create sugars and/or fatty acids, and (2) to convert the 
sugars/fatty acids to PHB. This process can be achieved in both 
plants and microbial photosynthetic organisms (Suriyamongkol, 
Weselake et al. 2007).  Library mutagenesis approaches are not 
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scaleable to plant systems, making cyanobacteria an attractive 
platform for IME approaches to improve PHB production.  
Identifying gene targets in Synechocystis is interesting to both 
engineer the organism and guide rational approaches for 
engineering plants for improved PHB production.  
In this study, we use an IME approach to generate a library 
of transposon-based gene disruptions in Synechocystis. This 
library is screened for improved PHB accumulation using a high 
throughput fluorescence activated cell sorting screen and gene 
disruptions are identified that increase PHB accumulation.  We 
have thus obtained improved strains as well as identified 
genetic markers for further improvements in other photosynthetic 
systems. 
4.2. Materials and methods 
4.2.1. Strains, culture conditions, reagents 
Synechocystis PCC 6803 was grown at 30ºC in BG11 medium 
(Rippka, Deruelles et al. 1979).  Cultures were grown in a 
light-tight incubator (E-36, Percival Scientific, Boone, Iowa) 
at continuous 100 µmol of photons m-2 s-1 provided by cool white 
fluorescent lightbulbs. Nutrient modifications to the growth 
medium were: BG11(P), a modified BG11 medium with 0.018 mM K2HPO4 
(10% of the concentration in BG11); BG11(A), BG11 supplemented 
with 10 mM sodium acetate; or BG11(P)(A), BG11(P) supplemented 
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with 10 mM sodium acetate.  Cells were cultured in 250 mL 
Erlenmeyer flasks with a foam stopper to allow gas transfer on a 
rotary shaker at 100 rpm. 
DH5α (Invitrogen, Carlsbad, CA) was used for cloning steps.  
pUC19 (Invitrogen, Carlsbad, CA) was used for various cloning 
steps and as a suicide vector for recombination in Synechocystis.  
Kanamycin (kan) was used at 50 µg/mL for DH5α and 100 µg/mL for 
Synechocystis. 
All restriction enzymes, ligases, Taq DNA polymerase, PCR 
and cloning reagents were purchased from New England Biolabs 
(Beverly, MA) and cloning was performed using standard protocols 
(Sambrook, Fritsch et al. 1989). 
4.2.2. Development of transposon library in Synechocystis 
A library of Synechocystis genomic DNA fragments cloned 
into pUC19 was kindly provided by DuPont Co.  In vitro 
transposon mutagenesis was performed on the purified plasmid 
library using EZ::TN<Kan-2> Insertion Kit (Epicentre 
Biotechnologies, Madison, WI).  This kit includes a transposon 
DNA fragment containing a kanamycin resistance marker held in 
the active site of a transposase that will randomly insert the 
transposon into the plasmids in the reaction mixture. Plasmids 
were subsequently transformed into DH5α, and transformants were 
plated on kanamycin Luria-Bertani (LB) agar plates, so only 
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plasmids with successful insertions were selected and amplified.  
About 20,000 kanR colonies were scraped from the LB plates and 
the plasmids were isolated using Qiagen Miniprep kit (Qiagen, 
Hilden, Germany).  The plasmids bearing segments of 
Synechocystis genomic DNA with transposon insertions were then 
transformed into Synechocystis by electroporation (Chiaramonte, 
Giacometti et al. 1999).  Wild type (WT) Synechocystis was grown 
to exponential phase (A730~0.5), washed twice with 0.3 volume 
deionized water, and finally resuspended in 0.02 volume (A730~14) 
deionized water.  40 µL cells were mixed with 2 µL mutagenized 
plasmid library (2.5 µg) and electroporated at 2.5 kV, 25 µF, 
200 Ω, using a Gene Pulser (Bio-rad, Hercules, CA) with 0.2 cm 
gap distance electroporation cuvette. The transformed 
Synechocystis was plated on BG11 agar plates with kanamycin and 
colonies that have the transposon recombined into the genome 
were selected and scraped into a single freezer stock after 10 
days. 
4.2.3. Flourescence-based PHB measurement and screening 
The Synechocystis library was inoculated into BG11, BG11(P), 
BG11(A), BG11(P)(A) to an A730=0.022 and cultured for 14 days.  
Cells were quantitatively stained with nile red to give a 
fluorescence signal proportional to PHB content (Tyo, Zhou et al. 
2006).  Briefly, cells were resuspended in deionized water to an 
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A730=0.4.  3µL of a 1mg/mL nile red (Sigma-Aldrich, St. Louis, 
MO), in dimethyl sulfoxide solution was used to stain 
intracellular PHB granules to fluoresce at 585 nm, and 1 uL of a 
1 mM bis-(1,3-dibutylbarbituric acid)trimethine oxonol (oxonol) 
(Invitrogen, Carlsbad, CA) was used as a live/dead stain which 
fluoresces at 530 nm.  Cells were incubated in the dark for 30 
min at room temperature then sorted on a MoFlo fluorescence 
activated cell sorter (FACS) (Dako, Carpinteria, CA).  Cells 
were sorted based on the PE filter set (for nile red 
fluorescence) and FITC filter set (for oxonol) Cells were 
collected that did not fluoresce for oxonol (living) and were in 
the top 0.1% of the nile red fluorescence distribution (high 
PHB).  Collected cells were plated on BG11 agar, and individual 
colonies were isolated.  The location of the transposon in high 
PHB producing isolates was identified using thermal asymmetric 
interlaced (TAIL) PCR (Liu and Whittier 1995) using primers 
homologous to the transposon insert (Table 4-1 TAIL primers).   
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4.2.4. Transferring transposon insertions to parental strain 
To verify the identified gene disruptions were sufficient 
for the observed changes in PHB production, the same transposon 
insertion was introduced into a WT Synechocystis.  This was 
accomplished by one of two methods, electroporation of PCR 
products (Chiaramonte, Giacometti et al. 1999), or recombination 
from a suicide vector (Vermaas, Williams et al. 1987).  For 
electroporation, a fragment of DNA including the transposon and 
750 bp flanking Synechocystis DNA on either side was amplified 
by PCR from the genomic DNA of the isolated mutant and gel 
purified.  Synechocystis was prepared for electroporation as 
above.  Suicide vector recombination relied on amplifying a 
similar PCR fragment that was cloned into pUC19 using NdeI and 
Table 4-1: Oligonucleotides used in Synechocystis study. 
Name Description Sequence (5’-3’) 
Identifying Transposon Location 
TAIL AD1  NTCGASTWTSGWGTT 
Kan-2 TAIL #1  ACACTGGCAGAGCATTACGCTGACTTG 
Kan-2 TAIL #2  CGGCGGCTTTGTTGAATAAATCGAACT 
Kan-2 TAIL #3  CAGACCGTTCCGTGGCAAAGCAA 
Integrating Transposons to WT 
slr1670(sense) NdeI GGAATTCCATATGAATTTACCTAGAGGTGTTTACGCCCCTGGG 
slr1670(anti) SacI ACGCGAGCTCAGTAATTCCAGATCACAGGCCGCCG 
sll0377(sense) NdeI GGAATTCCATATGTTGTTGATATTTTCCCAGTGTCGGCGGAGCT 
sll0377(anti) SacI ACGCGAGCTCTCCCAATTCCTCAATACCTTCAATGCGA 
sll0683(sense) NdeI GGAATTCCATATGTTGCTGTACCCATCGGCGTT 
sll0683(anti) SacI ACGCGAGCTCGCATTAACCCTTCAATCTTCAAG 
sll8035(sense) NdeI GGAATTCCATATGAACTGGGCTGAGTCCACAATGCGA 
sll8035(anti) SacI ACGCGAGCTCCGTAGTACCCGCATTAACTGCCCCG 
Validating Transposon Integrations 
slr1670(s) VAL  TGGGCAAAATCCCGTTGGGACTC 
sll0461(s) VAL  CGTTAGGCGACTCTGGATGGGATCA 
sll0565 (a) VAL  GCATTGTGGAACTGGCCCAACG 
sll0377(a) VAL  AGCTGGGGCCAACACTCCTAAACCC 
sll0683 (s) VAL  TGGATTCCCCTCTTTAGCACCCCG 
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SacI sites that were introduced in the primers.  The pUC vector 
with cloned Synechocystis flanked transposon was used to 
recombine the transposon to the same genetic location in WT 
Synechocystis by incubating the plasmid with exponentially 
growing cells and relying on the natural competency of 
Synechocystis (Vermaas, Williams et al. 1987).  Transformants 
were selected on kanamycin BG11 agar plates in both methods.  
Correctly transferred transposons were verified by PCR. 
4.2.5. PHB analysis 
PHB was analyzed as in Chapter 3.2.3 Chemical PHB Analysis  
4.3. Results 
4.3.1. Library development 
While transposon mutagenesis has been used routinely in 
other organisms to create gene disruption libraries that elicit 
different phenotypes, traditional approaches have proved 
unsuccessful in Synechocystis.  Instead a two step approach was 
used (Bhaya, Takahashi et al. 2001).  In vitro transposon 
mutagenesis was used first to insert kanamycin markers into 
plasmids that bear random fragments of Synechocystis genomic DNA 
(Figure 4-1(I)). After in vitro transposon mutagenesis of the 
Synechocystis genomic library, 20,000 KanR colonies harboring a 
genomic library with insertional mutagenesis were rescued for 
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amplification and isolation of mutagenized plasmids. In a second 
step, these mutagenized plasmids were transformed into wild type 
Synechocystis (Figure 4-1(II)), and the transposon integrated 
into the genome by homologous recombination determined by the 
flanking DNA on the plasmid (Figure 4-1(III)). The plasmid 
bearing the Synechocystis genomic DNA can not replicate in 
Synechocystis and was subsequently lost.  Because the flanking 
DNA on each plasmid was from a different region of the genome, 
the transposons inserted and disrupted individual genes in the 
genome.  10,000 mutants with transposons in random locations 
were generated by this method.  Given 3,168 ORFs, this gives 
about 3x coverage, or 95% confidence that each gene has been 
disrupted.  The constructed library can be screened for many 
different phenotypes and represents a useful library for 
photosynthetic organisms. 
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4.3.2. Library screening   
The transposon mutagenesis library was grown in four 
different media supplementations known to elicit varied PHB 
accumulation, BG11, BG11(P), BG11(A), and BG11(P)(A).  After 14 
days, cell populations were sorted by FACS and individual 
mutants with high fluorescence from nile red were isolated. 
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Figure 4-1: Library development strategy.   
(I) A commercial in vitro transposon / transposase kit is used to randomly insert transposon 
DNA into members of a Synechocystis genomic library cloned into pUC19.  [a,b,c are 
consecutive arbitrary sequences in the Synechocystis genome.  t is the transposon sequence 
including a kanamycin resistance marker.]  (II) The mutagenized genomic library is transformed 
into WT Synechocystis. (III) DNA sequences flanking the transposon are recombined with 
homologous fragments in the genome.  This integrates the transposon and causes a disruption in 
the gene.  The location of the integration will be determined by the region of DNA that was on 
the plasmid. 
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Figure 4-2(a) shows the sorting configuration of the FACS for 
the library grown in BG11.  FITC fluorescence of oxonol was used 
to identify dead cells so that only viable cells were sorted.  
Over the four nutrient conditions, 34 clones were isolated from 
the screen and further characterized. 
Each isolated mutant was regrown under conditions identical 
to those under which it was sorted.  PHB accumulation was 
estimated using the nile red fluorescence protocol after 7 and 
14 days (Figure 4-2(b)).  Fifteen clones that displayed 
significantly higher nile red fluorescence at one or both of 
these time points were further assayed using the more accurate 
HPLC-based method.  Of the 15 clones that were isolated from the 
FACS screening, improved PHB accumulation was confirmed by HPLC 
for only 8 (8 of 31 true positives isolated from the initial 
screen).  Figure 4-3 shows the measured PHB in these isolated 
clones.  The transposon insertion site for clones that had 
increased PHB was identified using TAIL PCR to amplify DNA 
adjacent to the transposon.  The genome location was identified 
by sequencing the adjacent DNA and BLASTing against the 
Synechocystis genomic sequence 
(http://www.kazusa.or.jp/cyanobase/).   
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Figure 4-2 Library screening.  
(a) Distribution of fluorescence measured by FACS in library grown in BG11.  Cells from the 
top 0.1% of the nile red (PHB) fluorescence distribution that were below the threshold for the 
dead stain (oxonol) fluorescence were chosen (square box).  Dead cells tend to emit high 
fluorescence in the nile red fluorescence range and would lead to sorting many non viable cells, 
but were avoided by detecting dead cells from the high oxonol fluorescence (oval)  (b) Nile red 
(PHB) fluorescence of cultures grown from isolated clones after 7 and 14 days.  Circled clones 
were chosen based on high nile red fluorescence at 7 or 14 days.  ♦ - Clones isolated from BG11 
■ – Clones isolated from BG11(P) ▲ – Clones isolated from BG11(A) ● – Clones isolated from 
BG11(P)(A) 
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To verify that the transposon insertion was sufficient for 
the increase in PHB accumulation, the transposon was introduced 
at the same site in the WT strain and the latter was assayed for 
improved PHB accumulation.  Figure 4-3 (Transposon directed to 
WT) shows the PHB accumulation of mutants identified from the 
screening step and the PHB accumulation after the transposon was 
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Figure 4-3 Quantitative analysis of isolated clones and transposons systematically 
introduced to WT by HPLC.   
PHB from isolated clones that were circled in Figure 4-2(b) was analyzed (blue).  For isolated 
clones that showed improvement, the transposon insertion was inserted into a WT strain at the 
same location to verify the transposon was sufficient for increasing PHB.  The dotted line 
represents the WT accumulation of PHB in each condition 
(BG11/BG11(P)/BG11(A)/BG11(P)(A) ).  WT PHB accumulation: BG11 = 3.5% BG11(P) 
[10% Phosphate] = 6.6%; BG11(A) [10 mM Acetate supplement] = 2.6% BG11(P)(A) [10% 
Phosphate with 10 mM Acetate supplement] = 12.5% (All are %PHB (DCW)).  
* - p-values <0.05  
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transferred to a new WT strain.  Of the 8 initial isolates, only 
4 transposon insertions were found to elicit increased PHB upon 
transferring the transposon to a WT strain, suggesting that 
additional chromosomal mutations may have contributed to the PHB 
improvements of the initial isolates. 
4.3.3. Location of transposon insertions 
Three insertions were found in sll0461 and one insertion in 
sll0565 (Figure 4-4).  sll0461 is a 1,263 bp ORF encoding a 
gamma-glutamyl phosphate reductase (proA) used in the metabolic 
pathway from glutamate to proline.  sll0461 is the first ORF in 
an operon with two other genes (ssl0900 and sll0462), encoding a 
very small hypothetical protein and a predicted permease, 
respectively.  A total of three clones were found with 
insertions in sll0461, two from the BG11 culture, and one from 
the BG11(A) culture.  The two mutants isolated from BG11 both 
had insertions in the same site, 770 bp from the start of the 
gene.  Translation of this transcript would yield a 267 aa 
product including 257 aa from the original sll0461, but 
truncating the last 164 aa.  The location of the transposon 
insertion isolated from the BG11(A) occurred at the end of the 
ORF at 1,112 bp, only changing the last 50 aa of the C-terminus.  
In both of these insertion events, the RNA polymerase is 
unlikely to transcribe through the transposon, preventing 
 94 
transcription of ssl0900 and sll0462.  It can not be determined 
by this study which of these three ORFs play a role in the 
altered PHB anabolism. 
 
sll0565 is a 401 bp ORF of unknown function that is the 
second ORF in a 2 gene operon.  The transposon in sll0565 was 
inserted at 307 bp, changing the last 31 aa, but keeping the 
length almost the same (133 aa for WT, 135 aa with transposon 
insertion).  This insertion occurs at the end of the operon, and 
does not inhibit the transcription of any downsteam ORFs. 
4.3.4. PHB accumulation in improved strains 
Growth and PHB accumulation phenotypes of the improved 
mutants, which were identified in either BG11 or BG11(A), were 
characterized in all four media conditions (BG11,BG11(P),BG11(A), 
and BG11(P)(A)).  Figure 4-5(a)-(d) show the growth profiles for 
the transposon insertions in the two ORFs compared to wild type.  
sll0565sll0564
Transposon Insertion Site
Open Reading Frame
sll0461 sll0462
ssl0900
500 bp
x2
(a)
(b)
 
Figure 4-4 Context of transposon insertions.  
(a) Locations of transposon insertions in sll0565. (b) Locations of transposon insertions in 
sll0461.  Green arrows are annotated ORFs. 
 95 
Without phosphate limitations (Figure 4-5(a),(c)), all cultures 
grew up to A730~12, while with lowered phosphate (Figure 
4-5(b),(d)), biomass could only accumulate to A730~3.  Under all 
growth conditions, there was no difference in the growth profile 
of the two mutants.  PHB accumulation at 7 days was not 
different from WT, but differences arose at 14 days (Figure 4-6).  
While both mutants had higher PHB accumulation in BG11, BG11(P), 
and BG11(A), the increases in BG11 were the largest.  
Interestingly, sll0565::kan was found to have improved yields of 
PHB in BG11, even though it was isolated from the BG11(A) 
condition, and both were found to have slight increases in PHB 
accumulation in BG11(P), though neither were found in this 
condition during the screen.  This implies that the mode of PHB 
accumulation in both strains is independent of acetate presence, 
does not inhibit growth, and becomes more pronounced at high 
cell densities.   
 96 
 
0
2
4
6
8
10
12
14
16
0 5 10 15 20
Time (days)
A
(7
3
0
)
WT
sll0461::TN
sll0565::TN
0
2
4
6
8
10
12
14
16
0 5 10 15 20
Time (days)
A
(7
3
0
)
WT
sll0461::TN
sll0565::TN
0
2
4
6
8
10
12
14
16
0 5 10 15 20
Time (days)
A
(7
3
0
)
WT
sll0461::TN
sll0565::TN
0
2
4
6
8
10
12
14
16
0 5 10 15 20
Time (days)
A
(7
3
0
)
WT
sll0461::TN
sll0565::TN
(a) (b)
BG11 BG11(P)
(c) (d)
BG11(A) BG11(P)(A)
 
Figure 4-5 Growth time course data for improved mutants in different growth media.  
(a) Growth of improved mutants in BG11.  (b) Growth in BG11(P) [10% Phosphate]. (c) Growth 
in BG11(A) [10 mM Acetate supplement]. (d) Growth in BG11(P)(A) [10% Phosphate with 10 
mM Acetate supplement].  ♦ - WT Synechocystis; ■ – Transposon inserted in sll0461 
Synechocystis; ▲ – Transposon inserted in sll0561 Synechocystis. 
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4.4. Discussion 
Inverse metabolic engineering strategy is dependent on 
genetic diversity in the library, and thereby the phenotypes 
that can be produced.  Transposon mutagenesis is an attractive 
technique for introducing genetic diversity because it only 
delivers one change per cell and the genetic change can be 
easily located and transferred to other host cells.  Genetic 
methods for direct transposon delivery are not available for 
Synechocystis as for more traditional model organisms like E. 
coli and S. cerevisiae. This forced a two step approach to 
transposon mutagenesis.  Both steps had to provide library sizes 
much greater than the number of Synechocystis genome ORFs in 
order to provide good overall coverage.  The first step, in 
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Figure 4-6 PHB accumulation of Synechocystis transposons. 
7 and 14 days.   Blue – 7 days; Red – 14 days.  BG11, BG11(P), BG11(A), BG11(P)(A) and 
strains as in Figure 4-5. * - p-value < 0.05. 
 98 
vitro transposon mutagenesis of the plasmid library, readily 
yielded ~20,000 transpositions when transformed into E. coli.  
The second step, transforming the mutagenized plasmids to 
Synechocystis, yielded ~1,500 transformations per standard 
reaction (~2×106 cells), consistent with previous observations 
(Kufryk et al. 2002).  Seven parallel transformations were used 
to scale up to the target size of 10,000 clones. 
There are inherent difficulties with screening for a 
phenotype by only measuring one cell compared to measuring a 
large clonal population.  This difficulty arises from the effect 
of sample size on the ability to estimate the mean of a 
population.  In this study, only 25% of the clones isolated from 
the FACS with the highest single cell PHB levels showed 
increased PHB accumulation upon measuring the population grown 
from that cell.  Unlike colony-based and 96 well-type screening, 
which rely on the averaged measurement of many cells from a 
clonal population, thereby precisely estimating the mean, FACS 
allows the measurement of only one cell, reducing the confidence 
that the measurement represents the mean. This is compounded by 
a very large variance caused by biological noise.  In a clonal 
population accumulating PHB, the coefficient of variation in PHB 
fluorescence is ~100% (data not shown).  The ability to separate 
cells whose means are not significantly larger than the 
biological variance is inherently difficult, because the 
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biological noise will be larger than the expected increases in 
PHB.  Protein evolution, which often uses single cell 
measurements, can obtain 10 fold increases in phenotype in a 
round of screening (Crameri, Raillard et al. 1998).  However, as 
was the case in this study, increases of 20%-50% are typical for 
metabolic fluxes, making the improved mutants difficult to 
isolate due to the biological noise.   
It was also observed that for many of the mutants that did 
exhibit PHB increases, the transposon insertion alone was not 
sufficient to elicit the improved PHB phenotype (Figure 4-3). 
This was the case in five of the eight mutants that had improved 
PHB, including the highest PHB accumulating mutants.  This 
implies that there are other genetic changes or epigenetic 
effects contributing to PHB accumulation independently or in 
cooperation with transposon insertions.  This is particularly 
true in the case of phosphate starvation, where significant 
increases in PHB were observed (up to 16% PHB (DCW)), but not 
linked to the transposon insertion (Figure 4-3, BG11(P)).  
Accessing the nature of these changes was not possible in this 
study.   
Two insertions were found to be sufficient for improved PHB 
production in Synechocystis under various culture conditions.  
These insertions were in proA, an enzyme in the proline 
biosynthetic pathway, and an unknown protein.  sll0461 encodes 
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one of two copies of proA found in Synechocystis, sll0373 being 
the other.  It is interesting to note that while three mutants 
were isolated with insertions in sll0461, none were found in 
sll0373.  Proline acts as an important protective osmolyte in 
higher plants and reduced cytoplasmic proline may signal other 
stress responses that favor PHB production.  In this context we 
note that ∆1-pyrroline-5-carboxylate synthase (P5CS1), a sll0461 
homologue in higher plants, is expressed in response to 
dehydration and high salt (Ábrahám, Rigó et al. 2003).  sll0462, 
a gene most likely silenced by the insertion in sll0461, is 
homologous to predicted permeases involved in the purR regulon 
in Nostoc punctiforme PCC 73102.  The insertions in the 
sll0461/sll0462 gene cluster affected PHB accumulation more 
dramatically at higher cell densities (14 day vs 7 day) and 
appeared to be suppressed by the presence of acetate in the 
media.  The transposon does not affect growth of the mutant, and 
the increased diversion of carbon to PHB suggests that there is 
excess carbon dioxide fixing capacity that could be harnessed 
for product formation.  sll0565 has significant homology to the 
myosin heavy chain (AT3G53350) in Arabidopsis thaliana, which is 
involved in locomotion along filamentous actin in plants 
(Kinkema, Wang et al. 1994).  As with sll0461, the insertion did 
not affect growth, and the differences in PHB accumulation were 
observed later in culture growth.  However, unlike the 
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insertions found in sll0461, the sll0565 mutant performed about 
the same regardless of acetate addition.   
While a biochemical mechanism could not be inferred by the 
location of the insertions, promising genetic loci have been 
identified for future studies.  Recently, there has been an 
emphasis on heterologous expression of the PHB operon in plants 
(Bohmert et al. 2000; Menzel et al. 2003; Poirier 2002).  As 
Synechocystis fixes carbon dioxide through the Calvin cycle, it 
is likely that targets found in Synechocystis could be relevant 
in future efforts to engineer higher plants for PHB production.    
In this work, we have generated genetic diversity by 
delivering gene insertions via transposon mutagenesis to 
Synechocystis.  The library was grown under different conditions 
known to affect PHB accumulation.  Using a fluorescence-based 
assay, the amount of PHB was estimated on a single cell level, 
and cells with high fluorescence for PHB were isolated from the 
library and characterized.  Insertions in two ORFs, sll0461 and 
sll0565, were found to significantly increase PHB in standard 
BG11 media, as well as, smaller improvements in acetate 
supplementation and phosphate limitation. 
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5 FME perturbations for PHB productivity in E. coli 
5.1. Introduction 
This chapter represents a shift from the combinatorial 
approaches of inverse metabolic engineering (IME) described in 
Chapter 3 & 4 to a more rationally-driven forward metabolic 
engineering.  IME approaches were pursued at great length in E. 
coli, but were not successful.  Although mutants could be found 
that increase PHB, these mutants could not successfully be 
related to the genetic perturbations that were introduced in the 
libraries.  As will follow, a case was built that the PHB 
productivity is controlled by the 3 step PHB biosynthetic 
pathway.  The PHB pathway was not genetically perturbed in the 
previous IME screenings, meaning changes outside the pathway 
could not increase PHB. 
In particular, we studied PHB formation in the setting of 
growth phase product formation.  Extensive literature, that was 
review in Chapter 2, has focused on batch phase operations, 
where the PHB is made primarily in stationary phase.  Because 
PHB is an intracellular product, there must always be enough 
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cellular biomass to surround the PHB granules.  It follows then, 
that PHB production could be achieved in a continuous manner, 
where biomass formation and PHB production occur simultaneously. 
Growth phase product formation requires a delicate balance 
between product formation and biomass formation (growth).  Given 
that specific substrate uptake rates are finite, the resources 
diverted to biomass formation and product formation can not 
exceed a defined rate forcing a trade off between the two.  
While product formation is the objective of a biochemical 
process, increasing product formation will eventually inhibit 
growth by starving the cell for resources necessary for growth 
or by the toxicity of accumulated products or intermediates in 
the product forming pathway, thus reducing the rate of 
biocatalyst production.  From an overall productivity, a 
precisely defined product formation rate is essential to 
maximize yield and productivity. 
This is especially true in the case of poly-3-
hydroxybutyrate, where the product is expected to use a large 
portion of the glucose uptake and is stored intracellularly 
(Anderson and Dawes 1990), thereby potentially hindering growth 
rate significantly.  PHB production in recombinant E. coli is 
attractive for a number of reasons: high yields are possible, 
purification of the polymer from E. coli is much easier than 
from the native organism, and there are no known PHB 
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depolymerases in E. coli  (Madison and Huisman 1999).  Chemostat 
processes may be attractive for PHB production in E. coli 
because continuous process enjoy greater utilization of 
installed capital, lower equipment sizes, and increased 
volumetric productivities (when calculated including down-times 
inherent in batch processes), which may be helpful for this low 
value product.  Furthermore, only a limited amount of PHB can be 
stored intracellularly, requiring simultaneous generation of 
both biomass and PHB for continuous production.  To date little 
work has explored continuous production for PHB.  Previous 
studies have shown that PHB accumulation primarily occurs in 
stationary phase and very little accumulation happens in log 
phase growth (Wang and Lee 1997).  These characteristics would 
not be amenable for growth phase accumulation, and thus new 
engineering strategies need to be employed to improve growth 
phase accumulation. 
Pathway activities have been implicated as a possible flux 
limitation.  In vitro enzyme activity measurements of the PHB 
pathway and kinetic models have implicated limitation in the 
pathway activity (Sim, Snell et al. 1997; van Wegen, Lee et al. 
2001).  In particular, AAR activity has been measured as low, 
although no direct experiments have shown whether this limits 
flux to PHB.  In this work, we study the effects of stepwise 
overexpression of the PHB pathway on pathway flux.  Separately, 
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the growth rate is varied through dilution rate in a nitrogen 
limited chemostat to vary biomass demand for acetyl-CoA.  These 
experiments show that the activity of the PHB pathway primarily 
controls PHB flux, and careful tuning of that pathway activity 
will be required for optimal product/biomass formation ratio. 
5.2. Materials and methods 
5.2.1. Strains, plasmids, primers and media 
Strains and plasmids used in this study are listed in Table 
5-1.  pAGL20, a modified pJOE7 kindly provided by Anthony 
Sinskey, contains the genes phaAB from R. eutropha, encoding the 
β-ketothiolase and the acetoacetyl coenzyme-A reductase, phaEC 
from Allochromatium vinosum, encoding the two-subunit PHB 
polymerase on a kanamycin resistant backbone (Lawrence, Choi et 
al. 2005).  pZE21 is a ColE1 plasmid with kanamycin resistance 
and green fluorescent protein (gfp) driven by a PL-tetO promoter 
(Lutz and Bujard 1997). 
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Cloning was performed using standard techniques and 
materials from New England Biosciences (Beverly, MA), and all 
cloning steps were performed in DH5α (Invitrogen).  Table 5-2 
lists all primers used for PCR.  pZE21 was digested SacI/AatII 
and ligated to a chloremphenical acetyl transferase PCR product 
from pAC184 bearing the same sites to create pZE-Cm.  
Promoterless PCR products of phaA, phaB, phaEC, and phaECAB, 
were generated from pAGL20 and cloned into the KpnI/MluI sites 
of pZE-Cm for the systematic overexpression study.  These 
plasmids were co-transformed with pAGL20 into XL-1 Blue and 
characterized.  Whole operon promoter replacement was 
accomplished by synthesizing the tac promoter from 
Table 5-1: Strains and plasmids used in E. coli study 
Name Description Reference 
Strains   
XL1-Blue Cloning/Expression Strain of E. coli Stratagene (La Jolla, Calif.) 
K12 recA::kan TGD 
(cat+PHB) 
30 tandem copies of PHB biosynthetic operon 
from pAGL20 on E. coli genome 
(Tyo and Stephanopoulos, Submitted) 
   
Plasmids   
pAGL20 PHB biosynthetic pathway on modified 
pJOE7 
(Lawrence, Choi et al. 2005) 
pZE21 Medium copy plasmid (ColE1 origin, kan
R
) (Lutz and Bujard 1997) 
pZE-Cm pZE21 with kan
R
 replaced with Cm
R
  
pZE-Cm-phaA pZE derivative with cat and R. eutrophus 
phaA 
 
pZE-Cm-phaB pZE derivative with cat and R. eutrophus 
phaB 
 
pZE-Cm-phaEC pZE derivative with cat and R. eutrophus 
phaA 
 
pZE-Cm-gfp pZE derivative with cat and gfp  
pZE-Cm-phaECAB pZE derivative with cat and pAGL20 PHB 
operon 
 
pZE-kan-tacpha pZE derivative with pAGL20 PHB operon 
driven by strong promoter (ptac) 
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oligonucleotides and cloning into the AatII/EcoRI site of pZE21.  
A promoterless phaECAB PCR product from pAGL20 was then cloned 
into the KpnI/MluI sites.  This plasmid was transformed into XL-
1 Blue and characterized. 
 
K12 recA::kan TGD(cat+PHB) was created using tandem gene 
duplication, and contains 25 copies of the phaECAB operon in 
tandem on the E. coli genome at the λ phage integration site(Tyo 
and Stephanopoulos 2008).  (Details of this strain will be 
presented in Chapter 6.)  This strain was used for the chemostat 
studies because of the improved genetic stability over plasmid-
based expression systems. 
Table 5-2: Oligonucleotides used in E. coli study. 
Name Restriction 
Site  
Sequence (5’-3’) 
Cm (s) AatII AAAGACGTCCGTTGATCGGCACGTAAGAGGTTCC 
Cm (a) SacI AAGAGCTCCCTTAAAAAAATTACGCCCCGCCC 
phaA (s) KpnI GGGGTACCGCATGACTGACGTTGTCATCGTATCCGC 
phaA (a) MluI CGACGCGTCGGAAAACCCCTTCCTTATTTGCG 
phaB (s) KpnI GGGGTACCGCATGACTCAGCGCATTGCGTATGTGAC 
phaB (a) MluI CGACGCGTCCGACTGGTTGAACCAGGCCG 
phaEC (s) KpnI GGGGTACCGACGGCAGAGAGACAATCAAATCATG 
phaEC (a) MluI CGACGCGTATGGAAACGGGAGGGAACCTGC 
tac promoter (s)  GAGCTGTTGACAATTAATCATCGGCTCGTATAATGTGTGG 
tac promoter (a) AatII / EcoRI AATTCCACACATTATACGAGCCGATGATTAATTGTCAACAGCTCACGT 
qPCR phaA (s)  CGTTGTCATCGTATCCGCCG 
qPCR phaA (a)  GACTTCGCTCACCTGCTCCG 
qPCR phaB (s)  GTGGTGTTCCGCAAGATGAC 
qPCR phaB (a)  CGTTCACCGACGAGATGTTG 
qPCR phaE (s)  GGAGCAGAGCCAGTATCAGG 
qPCR phaE (a)  CACCCTGGATGTAGGAGCCC 
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Strains were cultured in the minimal media, MR with 20 g/L 
glucose at 37oC (called MR from here forward).  MR medium was 
prepared as defined previously (Wang and Lee 1997).  Luria-
Bertani (LB) broth was used for growth on solid media and 
standard preparations of cells. 
5.2.2. Systematic overexpression studies 
XL-1 Blue was transformed with the prescribed plasmid(s).  
Colonies were picked and grown in a 14 mL culture tube with 5 mL 
of LB for 12 hrs.  0.5 mL of the culture was inoculated into a 
14 mL culture tube with 5 mL MR and cultured for 12 hrs.  Cells 
were then inoculated into a 250 mL Erlenymer flask with a 
working volume of 50 mL MR + 10 mg/L thiamine to a starting 
A600=0.015.  Cultures were grown to steady state growth and 
harvested at A600 = 2.0 - 2.5.  Prior experiments showed cells 
were at steady state, exponential growth at this point in the 
cell culture(data not shown).  Growth rate, % PHB (DCW), and 
transcriptional measurements were taken as described below.  
Specific PHB productivity was estimated as the product of growth 
rate and percent PHB (DCW), which is exact at the limit of 
steady state growth.  34 µg/mL chloramphenicol and/or 25 µg/mL 
kanamycin was used to maintain plasmids in each experiment. 
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5.2.3. Chemostats  
Nitrogen-limited chemostat experiments were performed in a 
3 L stirred glass vessel using the BioFlo 110 modular 
fermentation system (New Brunswick Scientific, Edison, NJ) with 
a 1 L working volume.  Bioreactor controllers were set to pH = 
6.9, adjusted by 6 N NaOH through controller, 30% dissolved 
oxygen, controlled by adjusting feed oxygen concentration, and 
temperature at 37oC, controlled by a thermal blanket and cooling 
coil.  Gas flow was set at 3 L/min and agitation at 400 rpm.  
Antifoam SE-15 (Sigma-Aldrich, St. Louis, MO) was diluted in 
water and added by peristaltic pump to control foaming.   
Sterile MR media without antibiotics was fed by peristaltic 
pump at flowrates of 50,100, and 300 mL/h and culture broth was 
removed from the reactor using a level-stat.  10 mL samples were 
taken for characterization after four residence times at a given 
flowrate.  Approach to steady state was verified by monitoring 
glucose concentration in reactor.  Three measurements, each 
spaced one residence time apart, were taken at each steady state.  
Ammonium, the only nitrogen source, was monitored semi-
quantitatively by NH4
+ test strips (Merck KGaA, Darmstadt, 
Germany), and was always below 10 mg/L (the lowest measurable 
value on the test strip).  Chemostats were run in replicate, and 
glucose was in excess at all points except D=0.1h-1, where a dual 
nutrient limitation existed.  Contamination was checked by 
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streaking broth on nile red LB plates and checking that all 
colonies were PHB+ by nile red fluorescence. 
5.2.4. Analytical methods 
Cell densities were monitored at 600 nm using an Ulstrapec 
2100pro (Amersham Biosciences, Uppsala, Sweden).  Cell and PHB 
concentrations were determined as previously described in 
Chapter 3.2.3.  Glucose concentrations were measured by a 
glucose analyzer (Yellow Springs Instruments, Yellow Springs, 
OH).  Acetate was measured by high-pressure liquid 
chromatography using an Aminex HPX-87H ion-exclusion column (300 
7.8 mm; Bio-Rad, Hercules, Calif.) and 14 mM H2SO4 mobile phase 
at 50oC and 0.7 mL/min.  Cell culture supernatant was kept at -
20oC before analysis. 
5.2.5. Transcriptional analysis 
RNA was isolated from growing cells at A600 = 2.0 using the 
RNEasy Protect Bacteria mini kit (Qiagen USA, Valencia, CA), 
according to the manufacturer’s protocol, and diluted to 20 
ng/µL total RNA.  60 ng isolated RNA was converted to cDNA using 
the ImpromII reverse transcriptase (Promega, Madison, WI) with 1 
µg random hexamers according to the manufacturer’s protocol.  
cDNA concentrations of phaA, phaB, and phaE were determined by 
qPCR using a Biorad iCycler and the iQ SYBR Green Supermix 
(Biorad) using 5 µL of a 100-fold dilution of the cDNA reaction, 
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according to the manufacturer’s protocol.  qPCR primers are in 
Table 2.  A standard curve was made using dilutions of pAGL20, 
cut once to relax supercoiling.  Controls without reverse 
transcriptase were used to verify that contaminating DNA was 
negligible.   
5.2.6. Flux balance analysis  
Flux balance analysis was done with a previously existing 
stoichiometric model (Edwards and Palsson 2000), supplemented 
with three metabolic reactions and one exchange flux which 
together allow for PHB synthesis from acetyl-CoA: i)  2 AcCoA   
AcAcCoA + CoASH; ii) AcAcCoA + NADPH  3HBCoA + NADP; and iii) 
3HBCoA  PHB + CoASH.  The exchange flux was PHB   ∅, 
representing the net formation and export of PHB from the 
metabolically active portion of the cytoplasm.   
The stoichiometric trade-off between growth yield and PHB 
yield (on glucose) was calculated as described by Bell and 
Palsson (see the introduction of (Bell and Palsson 2005)).  
Briefly, the PHB yield was constrained to a certain value s, 
biomass yield was maximized subject to the usual FBA constraints 
as well as the PHB constraint.  By repeating the optimization at 
varying values of s, we obtained the full projection, in the two 
dimensions of PHB yield and biomass yield, of the feasible 
region of flux space.  
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Calculations were done with MATLAB software (The Mathworks, 
Natick MA), and the TOMLAB interface (Tomlab Optimization, Inc., 
Trefasgatan, Sweden) to the linear program solver CPLEX 9.0 
(ILOG, Gentilly, France). 
Biomass and PHB yields calculated from the model were 
converted to productivities by multiplying by the specific 
glucose uptake rate.  Glucose consumption was measured at 1.1 g 
glucose gRCW-1 h-1, yielding a maximal growth rate (from 
stoichiometric model) of 0.57 h-1 and maximal PHB production rate 
of 530 mg PHB / gRCW-1 h-1. 
5.3. Results 
5.3.1. Validating conditions for balanced growth 
Measuring PHB specific productivity was a key parameter in 
the analysis of PHB pathway regulation.  The direct measurements, 
growth rate and PHB content, must be taken while the cells are 
growing at steady state.  While chemostats were used in the 
second part of the study to measure productivities, chemostats 
were not conducive to measuring many different strains in 
parallel.  Instead, a protocol was developed to measure PHB at 
pseudo-steady state, or balanced, growth in shake flasks.  To 
this end, we measured the PHB accumulation from early log phase 
through early stationary phase in a shake flask (Figure 5-1).  
Because it was difficult to have a repeatable lag phase, data 
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was analyzed vs A600 rather than vs time.  As can be seen, PHB 
content is high as the cell begins to grow, due to accumulation 
from the stationary phase inoculum.  As the initial effects are 
diluted away by growth, the PHB content falls.  Finally, as the 
cells enter stationary phase, growth slows, and the PHB content 
rises again.  Between A600 = 2-3, the PHB is constant, and 
represent a regime where PHB accumulation is at steady state.  
To verify the PHB accumulation was at steady state, balanced 
growth, the strain were subcultured into pre-warmed shake flasks 
as the culture approached A600=2, and the PHB content was 
measured over several subculturings (data not shown).  PHB 
content did not change, confirming that the PHB accumulation was 
at steady state.  The region between A600 = 2-3 was chosen for 
further assays.   
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Figure 5-1:  PHB accumulation during batch growth. 
XL-1 Blue (pAGL20) was grown in a shake flask in MR.  PHB content was measured as the 
culture reached different cell densities.  (A) Cell density vs time.  (B) PHB vs time. (C) PHB vs 
Cell density.  Direct comparisons between experiments were best done based on cell density 
rather than time, due to highly variable lag phases.   
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5.3.2. Model estimates of PHB pathway flux control 
To better understand how the PHB flux might respond to 
changes in activity of the PHB pathway enzymes, a sensitivity 
analysis was performed using the model by van Wegen, et. al. 
(2001).  Matlab code used for this analysis is in Appendix I.  
Figure 5-2 shows the variation of phaA, β-ketothiolase (β-KT), 
and phaB (AAR), while phaEC (PHB synthase) is held constant.  
Other model parameters, such as precursor and co-factor 
concentrations, were set at published values for E. coli.  The 
model shows that at the native expression levels, the PHB flux 
is most sensitive to changes in AAR.  After AAR activity is 
increased 3-fold however, β-KT becomes limiting.  This matched 
well with our results which showed phaB limited flux to PHB, but 
after the phaB limitation is relieved, whole operon expression 
was necessary to achieve higher levels. 
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5.3.3. Systematic overexpression of PHB pathway 
The sensitivity of PHB specific productivity to 
perturbations in PHB pathway expression levels was analyzed by 
sequential overexpression of the phaA, phaB, and phaEC genes in 
the background of a second plasmid (pAGL20) that expressed the 
entire PHB operon from the native R. eutrophus promoter.  We 
hypothesized that the flux control would lie in the activity of 
the product forming pathway and not in the precursor 
availability (acetyl-CoA or NADPH) during growth on glucose.  
Figure 5-3 shows the increase in transcript levels and the 
 
Figure 5-2:  Predicted enzyme activity effects on PHB productivity. 
Intersection of dotted lines are the measured activities of β-ketothiolase and acetoacetyl-CoA 
reductase.  Solid line is the ratio of the two enzymes that has the steepest ascent (flux control 
equally distributed).  Heat plot is increasing flux to PHB [µM PHB monomer min
-1
].   
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corresponding phenotypic change in PHB production for each of 
the three overexpressions compared to the controls.  GFP 
overexpression was included to control for additional burden to 
the cell by a plasmid/gene product unrelated to PHB.  Figure 
5-3(a) shows the transcript levels were increased by two- to 
five-fold for each of the three genes.  phaB exerts the most 
flux control over the system and increases the growth-phase 
specific PHB productivity by 37% (Figure 5-3(d)).  The other two 
steps in the pathway, phaA and phaEC, do not increase the flux 
to PHB upon overexpression, and therefore do not exhibit flux 
control over the pathway.  While GFP did increase the PHB 
accumulation (Figure 5-3(b)), this is primarily due to a 
decrease in growth rate (Figure 5-3(c)), while productivity 
remained unchanged (Figure 5-3(d)).  To our knowledge, this is 
the first experimental determination that phaB is the limiting 
step in the PHB pathway.  The maximal specific growth rate was 
inversely related to the PHB productivity (Figure 5-3(c)), as 
might be expected for either (1) an increased diversion of 
carbon from biomass to PHB or (2) more intracellular PHB causing 
toxicity in the cytoplasm, as seen in the PHB accumulation 
(Figure 5-3(b)). 
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Overexpression of the entire pathway by complementing the 
pAGL20 plasmid with a second plasmid driving the whole PHB 
operon or by only one plasmid with a strong Ptac promoter 
revealed further increases in flux were possible. Figure 5-4 
shows the transcriptional and phenotypic effects of 
overexpressing the entire operon.  While phaB overexpression 
removed the AAR limitation, by overexpressing all three genes, 
additional limitations were overcome, resulting in productivity 
increases of 170% (270% above pAGL20).  While the highest 
transcriptional levels were measured when both plasmids were 
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Figure 5-3: Systematic overexpression of steps in PHB pathway. 
phaA, phaB, phaEC, and gfp were overexpressed in the presence of a second plasmid containing 
the complete PHB operon.  Strains were characterized in exponential phase.  (a) RNA levels (b) 
Exponential phase PHB accumulation (c) Specific growth rates        (d) Specific PHB 
productivity.  RCW – Residual cell weight, non-PHB fraction of biomass. 
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expressing the operon (pAGL20 + pZE-phaECAB), the highest PHB 
productivity was with only one plasmid using a strong Ptac 
promoter.  This is presumably because additional carbon and 
energy requirements involved in replicating a second plasmid 
limit PHB productivity.   
 
 
As before, increases in PHB productivity were correlated 
with decreases in growth rate.  This was specifically true for 
other promoters (PT5, PrrnB) stronger than Ptac (data not shown).  
When inoculated in MR medium, strains with these promoters grew 
extremely slow (growth rates of ~0.03 h-1), and the strains were 
genetically unstable: cells defective in PHB production quickly 
overtook the culture (data not shown).  While genetic 
instabilities made these strains impossible to characterize, it 
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Figure 5-4: Overexpression of entire PHB pathway.  
The PHB operon was expressed by one or two plasmids with different promoters.  Strains were 
characterized in exponential phase.  (a) RNA levels (b) Exponential phase PHB accumulation 
(c) Specific growth rates (d) Specific PHB productivity.  RCW – Residual cell weight, non-PHB 
fraction of biomass. 
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is suspected that PHB productivities exceeded a threshold beyond 
which resource consumption or toxicity due to large PHB granules 
reduces the growth to almost nothing.  This represents a regime 
of PHB pathway expression where the PHB/biomass ratio has become 
too high and is prohibitively toxic to the cell. 
5.3.4. Nitrogen-limited chemostat PHB production 
PHB productivity measurements in chemostats allowed us to 
vary growth rates by controlling the dilution rate under aerobic, 
nitrogen-limiting conditions.  In contrast to the overexpression 
experiments, where the PHB productivity was changed and the 
cells were allowed to grow at their maximal growth rate, here 
the growth rate is constrained, but the relative expression of 
the PHB pathway is held constant.  Table 5-3 shows the measured 
parameters of the strain at three dilution rates.  Figure 5-5 
shows the specific uptake and diversion of glucose to various 
metabolites and biomass. 
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Table 5-3: PHB production in chemostat 
Dilution Rate 0.05 h
-1 
0.10 h
-1
 0.30 h
-1
 
% PHB (DCW) 49% 37% 22% 
Yield (g PHB/ g GLU) 0.10 0.09 0.08 
% of Theoretical Max Yield 20% 20% 17% 
 
Concentrations X 3.1 3.3 3.5 
[g/L] PHB 2.9 2.0 1.0 
 ACE 2.5 2.5 1.1 
 GLU 0.3 9.1 17.8 
Volumetric 
Productivities X 0.15 0.33 1.04 
[g/(L h)] PHB 0.15 0.20 0.29 
 ACE 0.13 0.25 0.32 
 GLU 1.48 2.09 3.66 
Specific 
Productivities X 0.05 0.10 0.30 
[g/(g biomass h)] PHB 0.05 0.06 0.08 
 ACE 0.04 0.08 0.09 
 GLU 0.48 0.63 1.05 
X – non-PHB cell weight; PHB – poly-3-hydroxybutyrate; ACE – acetate; GLU - glucose 
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Figure 5-5: C-mol fluxes in PHB nitrogen-limited chemostat.   
K12 recA::kan TGD(cat+PHB) was grown in a nitrogen-limited chemostat.  Steady state rates 
of metabolite formation/consumption were measured and converted to C-mols.  Glucose 
consumed for biomass (non-PHB), PHB, and acetate was based on assumed yields.  Assumed 
yields on glucose; Biomass (residual cell weight) - 0.41 g/g, PHB - 0.48 g/g, Acetate – 0.66 g/g.   
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An excess of glucose (under nitrogen limiting conditions) 
provided an abundant substrate supply for PHB accumulation, 
although at the lowest dilution rate, the glucose was also 
completely consumed.  This is presumably due to increased 
maintenance requirements in the cell.  Non-PHB biomass 
concentration was constant at all dilution rates and was 
determined by the concentration of nitrogen in the feed (and the 
biomass yield of E. coli on ammonium).  Changes in specific 
glucose uptake were accounted for by the change in glucose 
demand for biomass as seen by the parallel lines in Figure 4.   
Although the amount of PHB increased in the reactor with 
decreasing dilution rate, the yield and specific productivity 
remained relatively constant.  PHB specific productivity only 
changed by a factor of 1.6 for the six fold change in growth 
rate, which was the least change for all metabolites and biomass 
measured.  Acetate production was present, consuming as much 
glucose as PHB, and was also insensitive to the dilution rate, 
even though the dissolved oxygen was kept above 30% throughout 
the experiment. 
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5.3.5. Comparison of experimental observations to a stoichiometric 
maximal model 
The observed trend between PHB productivity and growth rate 
is well inside the stoichiometrically optimal envelope of PHB 
productivity as function of growth rate.  Figure 5-6 shows the 
data from the overexpression studies and chemostat study 
overlaid with the stoichiometric envelope constraining the 
relationship between the flux to PHB and the flux to growth.  
The envelope was based on a genome-scale metabolic network model 
of E. coli metabolism (Edwards and Palsson 2000) modified to 
include the PHB reactions.   
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In the overexpression study, pathway expression was changed 
but cell growth was unconstrained.  That is, each strain grew in 
batch culture at its strain-specific maximum.  The trend in the 
overexpression data shows a tradeoff between product formation 
and growth, which is broadly similar to the predictions of the 
stoichiometric model.  The overexpression data falls well to the 
left of stoichiometrically optimal growth rate envelope.  Part 
of the reason for the discrepancy is E. coli K12’s well known 
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Figure 5-6: Comparison of overexpression and chemostat study to stoichiometric model 
for PHB in E. coli. 
PHB productivities and specific growth rates from overexpression and chemostat studies are 
compared to the maximal stoichiometric trade off.  Line represents an E. coli stoichiometric 
model (see text).  Stoichiometric model was used to predict the biomass yield at different PHB 
yields.  Data points for overexpression and chemostat studies are for all perturbations attempted. 
Red line – Linear regression of overexpression study; Blue line – Linear regression of chemostat 
study 
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acetate overflow metabolism, which allows faster growth at high 
glucose concentrations, at the penalty of stoichiometrically 
submaximal biomass yields.   Another reason may be the use of an 
XL-1 Blue background strain in this study, as opposed to the 
wild-type K12 for which the stoichiometric model was developed. 
However, the observed tradeoff between PHB productivity and 
cell growth was close to stoichiometrically optimal, as 
parameterized by the slopes of the lines in Figure 5-6.  Under 
the low-growth segment of the stoichiometric envelope, the 
stoichiometrically optimal tradeoff between PHB and biomass was 
610 mg PHB / gDCW.  The slope of the high-growth segment was 
~1280 mgPHB/gDCW.  The best-fit line through the overexpression 
data showed that the observed trade-off was approximately 680 mg 
PHB / gDCW.  This analysis suggests that PHB productivity 
competes with cell growth for access to carbon, and is limited 
by the flow of carbon into the PHB biosynthesis pathway.  
Granule toxicity and other non-stoichiometric affects appear 
less important.   
In contrast, in the nitrogen-limited chemostat at low 
dilution rates, we hypothesized that specific glucose uptake 
rates would remain relatively unchanged, allowing glucose 
previously required for biomass formation to be diverted to PHB, 
resulting in an increased PHB productivity.  Surprisingly, the 
data did not support our hypothesis and instead revealed a flat 
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relationship between PHB productivity and growth rate.  At lower 
growth rates, E. coli was unable to direct surplus glucose 
available in the chemostat environment toward PHB production, 
although it should be feasible in the stoichiometric space 
calculated.  This fact suggests that glucose uptake was 
regulated, even under nitrogen limitation, such that acetyl-CoA 
pool sizes were approximately constant regardless of growth rate 
or glucose availability. 
5.4. Discussion 
This study focuses on the effect of pathway enzyme 
expression and growth rate on PHB productivity.  PHB screening 
studies, an inverse metabolic engineering approach, was carried 
out for E. coli in an analogous manner to that for Synechocystis 
as described in Chapter 4.  However, increasing PHB productivity 
by introducing random genetic diversity and isolating improved 
PHB mutants, was unsuccessful in finding improved mutants that 
could be linked to the genetic changes in the library.  The 
genetic diversity introduced in the E. coli libraries, unlike 
the Synechocystis libraries, would be expected to perturb the 
global metabolic network and would most likely produce improved 
mutants by increasing the supply of precursors (acetyl-CoA or 
NADPH). Because no mutants could be found that improved PHB 
productivity, it was hypothesized that limitations in the 
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product-forming pathway (which would not be expected to be 
perturbed in the libraries) may control the rate of PHB 
formation.  This lead us to a forward metabolic engineering 
approach for improving PHB productivity in E. coli. 
PHB productivity was very sensitive to pathway expression, 
and in particular to AAR.  While other studies have implied AAR 
is limiting, to our knowledge, this is the first direct 
experimental determination in vivo.  The systematic 
overexpression approach used here was able to unambiguously 
identify phaB as exerting the most flux over PHB production.  
Overexpression of the entire operon led to much higher PHB 
productivities.  At the highest expression levels using PT5 and 
PrrnB, the diversion of acetyl-CoA to PHB almost stopped cell 
growth on glucose (data not shown).  This would indicate that 
when PHB flux is high enough to bring the acetyl-CoA and/or 
NADPH concentrations to below the Km for the PHB pathway, the 
levels are already to low for cellular functions to behave 
normally, or else intracellular PHB granules have began to 
strongly interfere with cellular processes.  These results show 
that PHB productivity can be manipulated over all possible 
fluxes by only manipulating the expression of the product-
forming pathway, and that precursor shortages may occur, not in 
a fashion where the product-forming pathway is underutilized, 
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but perhaps where cellular function is inhibited by loss of an 
essential intermediates. 
These limitations in the PHB pathway are consistent with 
the low in vitro AAR activities observed in previous studies 
(Sim, Snell et al. 1997; van Wegen, Lee et al. 2001).  In our 
experiments, as in most studies, PHB is expressed in medium/high 
copy (+25) from plasmids or tandem genes.  AAR activities in R. 
eutrophus have been reported at 0.2-0.3 U/mg total protein (Park 
and Lee 1996), while AAR activities in E. coli are much less at 
0.05 U/mg total protein (Lee, Kim et al. 1996).  This five fold 
change in activity may be the result of problems in the 
expression or activity of AAR.  Additionally, PHB synthase has 
been shown to be regulated by acetyl phosphate levels, and may 
be repressed under conditions in E. coli (Kessler and Witholt 
2001).  This agrees with the acetate production observed in the 
chemostat.  Diverting carbon from acetate to PHB would increase 
PHB yield but may require protein engineering on the PHB 
synthase to deregulate PHB synthase from allosteric effects that 
inhibit its activity, such as acetyl phosphate regulation.   
PHB productivity reveals the metabolic changes more clearly 
than PHB accumulation.  While our strategy of perturbing the 
metabolic network through changes in growth rate under nitrogen-
limited conditions is not more sophisticated than other 
techniques described previously, those experiments focused on 
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PHB accumulation.  PHB accumulation measurements are subject to 
both changes in PHB productivity and growth rate.  This was seen 
in the GFP control in Figure 5-3 and PHB accumulation and 
productivity in Table 5-3.  In both cases the PHB specific 
productivity was constant, although percent PHB (DCW) varied.   
It is important to note that altering the levels of the PHB 
synthase has been show to have an effect on the quality of the 
PHB, specifically the molecular weight (Sim, Snell et al. 1997).  
In this study we have focused on the flux to the PHB pathway and 
the quantity of PHB.  For commercial production, appropriate 
expression of the PHB synthase will be determined by the desired 
MW. 
Understanding that the flux control is primarily in the 
product-forming pathway allows the engineer to have a great deal 
of control over PHB productivity by controlling the expression 
levels of the PHB pathway.  For batch production, expression 
systems that suppress PHB production during growth phase and 
turn it on to a high level in stationary phase would be the most 
effective, by completely separating biocatalyst formation from 
product formation.  Continuous production could either take 
place as two chemostats in series with the first generating the 
biocatalyst and the second producing the product (analogous to 
the batch process), or as a single chemostat where the 
biocatalyst and product are produced simultaneously.  In the 
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latter case, a precisely tuned expression level would be 
required to maintain a PHB/biomass ratio that maximizes total 
productivity.  As observed, an upper limit of expression exists 
where too much carbon is diverted to PHB resulting in a 
PHB/biomass ratio which has very low cell viability and growth.   
Thus, through simple and systematic studies perturbation of 
gene expression levels, we resolved the long-standing debate in 
the literature about the rate-controlling step of PHB 
production:  AAR is rate-limiting.  More than two decades of 
prior study did not reach this result because most experimental 
perturbations in prior approaches suffered from diverse, and 
often unknown, pleiotropic effects.  Our study was the first to 
carefully manipulate relevant variables in isolation of more 
global systemic changes.  The increases in specific productivity 
that are now possible should improve economics of both existing 
batch processes, as well as open up opportunities for continuous 
processes. 
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6 Tandem Gene Duplication 
6.1. Introduction 
As mentioned in Chapter 5, as PHB expression level was 
increased, mutations quickly became a problem.  It is unlikely 
that the increase in PHB expression initiated mutations but did 
significantly increase the growth advantage caused by cells that 
did not make PHB (an increase in growth rate from 0.03 h-1 to 
0.32 h-1).  This overtake of the culture by mutants that loss 
productivity happened in the course of seven doublings in the 
shake flask (Materials and Methods, Chapter 5).  While PHB 
productivities had reached very attractive levels as the result 
of high PHB expression levels, the genetic stability, and 
resultant loss of productivity, made even batch culture highly 
problematic. 
Plasmids are an important tool for the recombinant 
production of proteins and heterologous enzymes in many 
organisms and are responsible for the production of many 
specialty chemicals, biologics, small molecule drugs, and other 
chemicals.  However, this is particularly true in systems where 
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large gene doses are required, as we saw with PHB expression.  
Plasmids have problems with genetic instability that reduce the 
number of active recombinant alleles in a cell that arise from 
(1) segregational instability, the result of unequal 
distribution of plasmids to daughter cells, and (2) random 
mutations to alleles carried on these plasmids.  Because 
recombinant alleles typically reduce growth rate, both 
mechanisms can result in subpopulations that grow faster and 
have fewer intact recombinant alleles than the parent cell, 
resulting in decreased productivity.  Selectable markers and 
partitioning elements mitigate the effects of segregational 
instability.  Such methods have allowed advances by avoiding 
plasmid-less population; however, they are suboptimal because it 
only imposes a minimal copy number and can require expensive 
antibiotics.  These genetic instabilities inherent in plasmid 
propagation have negatively impacted the development of 
continuous processes and have contributed to the majority of 
recombinant processes to batch.   
Selectable markers and partitioning elements are not able 
to prevent DNA mutations that eliminate activity or prevent 
plasmid containing DNA mutations from propagating.  For a 
plasmid containing a selectable marker and an expression allele 
in a cell under the appropriate selection conditions, the system 
will evolve to a population of plasmids that have intact 
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selectable markers, but have lossed productivity of the desired 
recombinant protein.  We put forward that this activity loss is 
not determined by the sequential inactivation of different 
copies due to DNA replication errors, but by ‘allele 
segregation,’ that is the accumulation of plasmids with inactive 
production alleles due to the random distribution of the 
original and mutated alleles from mother to daughter cell, 
biased by a growth advantage of the daughter cell containing 
fewer copies of the original allele. 
The loss of productivity due to allele segregation is 
expected to be much faster than by sequential DNA replication 
errors alone.  For a typical 40 copy plasmid recombinant 
expression system (see Appendix I for details), a basal DNA 
mutation rate of 5.4×10-10 errors/bp copied (Drake, Charlesworth 
et al. 1998) will result in a DNA mutation in ~13 generations.  
If random replication errors prevailed, it would take ~520 
generations to lose activity of all copies of the allele.  
Allele segregation is expected to happen much faster due to the 
probability that after a mutated plasmid is copied, both copies 
of a mutated allele can be inherited by the same daughter cell.  
A simple statistical calculation using binomial distribution of 
mutant plasmids from mother to daughter cells, and weighted by 
an expected growth advantage for cells containing more mutant 
plasmids predicts that a subpopulation containing only mutant 
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plasmids could form in ~20 generations and overtake the culture 
in an additional ~12.  Allele segregation is therefore expected 
to dramatically decrease the time that all copies of an allele 
are inactivated in a culture from ~520 generations to ~45.  A 
method of expressing many copies of a recombinant allele that 
avoids allele segregation significantly increase the lifetime 
that a population would be productive in a biotech process.  
Tandem gene duplication (TGD) is a naturally occurring 
phenomenon that generates many head-to-tail repeats of a DNA 
sequence in the genome (Zhang 2003), giving rise to many copies 
of an allele that are not subject to allele segregation.  TGD 
has been studied extensively in the context of evolutionary 
biology, but to date has not been shown to be genetically stable 
for recombinant expression (Xiaohai Wang 1996; Olson, Zhang et 
al. 1998).  By avoiding allele segregation, TGD can play a very 
important role in the introduction of new pathways and 
expression of single genes impacting product formation in 
microorganisms and other application of metabolic engineering 
and synthetic biology.   
The TGD mechanism causes gene duplication events to occur 
between two regions of high sequence homology driven and 
selected by a growth advantage conferred for each additional 
copy (Figure 6-1(a)).  An unequal crossover between the two 
homology regions on opposite strands (Figure 6-1(b)) occurs 
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after the replication fork.  This crossover event is recA 
dependent in prokaryotes and yields two strands of DNA, one 
containing two copies of the region between the homologous sites 
and another with that region deleted (Figure 6-1(c)).  Each of 
these strands is passed down to one daughter cell (Figure 
6-1(d)).  If a growth advantage is conferred by multiple copies 
of the region, the cell containing the tandem genes will begin 
to overtake the population and be available for further rounds 
of duplication (Figure 6-1(e)).  This process can continue, and 
has been observed to make up to 200 copies of the inter-
homologous region (Andersson, Slechta et al. 1998).  If 
conditions change such that a growth advantage is given for 
fewer copies, the copy number can be reduced by the same process.  
To prevent this, recA is deleted (Figure 6-1(f)), thereby 
preventing the crossover step and fixing the copy number. 
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The engineering strategy was to construct a DNA cassette 
containing gene(s) of interest and chloramphenicol acetyl 
transferase (cat), flanked on both sides by identical, non-
coding 1 kb regions of foreign DNA that has low homology to any 
other region of the E. coli genome.  The large identical regions 
served as homology regions for the crossover event, and 
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Figure 6-1: Tandem gene duplication: construction, amplification, and stabilization. 
(a) A construct is delivered to the genome that contains an antibiotic marker and the gene(s) of 
interest flanked by homologous regions (b) recA mediates an uneven homologous crossover 
between regions flanking the antibiotic marker and gene of interest. (c)  This generates a strand 
with two copies of the cassette and another with a deletion.  (d) One daughter cell inherits the 
two repeats while the other daughter cell looses the insert.  (e) Antibiotics are used to provide a 
growth advantage for the cell with increased repeats.  The process can then repeat itself to 
increase the number of duplications.  (f) Finally, recA is deleted to prevent further change in 
copy number.  [A] Homologous region (1 kb of chlB from Synechocystis PCC6803) [B] 
Antibiotic Resistance Gene (chloramphenicol acetyl transferase) [C] Gene of Interest 
(Polyhydroxybutyrate operon) 
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increased tolerance to chloramphenicol was used to provide a 
growth advantage for cells containing duplicated genes.  The 
construct was delivered to a wild type E. coli genome and 
subcultured in increasing concentrations of chloramphenicol.  
Once the cells have developed a resistance to the desired 
concentration of chloramphenicol and therefore have reached a 
desirable number of duplications, recA was deleted to prevent 
any further increase or decrease in copy number.  At this point, 
the strain expressed the gene(s) according to the gene dosage 
and did not require the chloramphenicol to maintain the copy 
number.  In this work we describe the methods to achieve the 
engineering strategy described above and present experimental 
evidence for the improved genetic stability that is achieved by 
tandem gene duplication and its application to metabolic 
engineering of the PHB pathway. 
6.2. Materials and Methods 
6.2.1. Strains and media 
E. coli K12 was used for the host strain of all tandem gene 
duplications.  DH5α (Invitrogen) was used for cloning steps.  
XL1 Blue was used for long term plasmid comparison experiment.  
Lysogens and transfer strains used in the λInCh protocol were 
kindly provided by Dr. Dana Boyd and Dr. Jon Beckwith (Boyd, 
Weiss et al. 2000).  BW 26,547 recA::kan Lambda recA+, generated 
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by Barry Wanner, used for P1 phage transduction of the recA 
deletion allele to the TGD strains, was received from Bob Sauer.  
Genomic DNA was isolated from Synechocystis PCC6803 using the 
Wizard Genomic Purification kit (Promega).  pZE-kan-tacpha is as 
described in Chapter 5.  Luria-Bertani broth was used for 
routine culturing and for tandem gene amplification.  PHB 
production was measured when grown in minimal MR medium (Wang 
and Lee 1997) with 20 g/L glucose. 
6.2.2. Construction of TGD strain 
All oligomers used in cloning are in Table 6-1.  pTrcHis2B 
(Invitrogen) was digested by SphI & ClaI, blunted by Mung Bean 
Nuclease and ligated to yield only the pBR322 origin and β-
lactamase.  Overlap PCR (Pont-Kingdon 2003) was used to connect 
a 1 kb region of chlB from Synechocystis PCC6803 to the 
chloramphenicol acetyl transferase (cat) from pAC-LYC.  The 
resulting DNA, followed by another copy of the chlB were 
sequentially cloned into the multicloning site of the pTrcHis2B-
derived plasmid.  This plasmid, pTGD, was used as a general 
integration platform (Figure 6-2).  The phaECAB operon with tac 
promoter and optimal RBS from a modified pAGL20 were cloned into 
the SphI/MluI sites.  The resulting DNA constructs were 
transferred from the plasmids to the genome of K12 E. coli using 
the λInCh protocol (Boyd, Weiss et al. 2000).  This protocol 
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delivers the plasmid construct to the genome, followed by a 
recombination step that removes the phage DNA from the genome. 
 
 
Table 6-1: Oligonucleotides used in TGD study. 
Name Description Sequence (5’-3’) 
Int P1 chlb (s) GCACCCTACGCATCGCCAGTTCTT 
Int P2 chlB (a) CGCTCTCGGGCAAACTTTTCTGTGTT 
Int P23 Overlap primer for Anneal-Extend PCR GGAACCTCTTACGTGCCGATCAACGGC
CCCGTTGTCTTCACTGATCAACACT 
Int P3 cat (s) CGTTGATCGGCACGTAAGAGGTTCC 
Int P4 cat (a) CCTTAAAAAAATTACGCCCCGCCC 
Lam P1(s) BamHI used for pTGD construction TATCGGATCCCCAGTTCTTTCAAAAAC
GTCCACGCC 
Lam P4(a) SacI SphI used for pTGD construction GGGAGCTCAGCATGCCCTTAAAAAAAT
TACGCCCCGCCC 
Lam P7(s) EcoRI MluI used for pTGD 
construction 
GGAATTCAACGCGTCCAGTTCTTTCAA
AAACGTCCACGCC 
Lam P8(a) XbaI used for pTGD construction CGTCTAGAGCCCCGTTGTCTTCACTGAT
CAACACT 
PHB (s) SphI used for pTGD cloning GCAAGCATGCAGCTTCCCAACCTTACC
AGAGGGCG 
PHB (a) MluI used for pTGD cloning GCACGCGTCGGCAGGTCAGCCCATATG
CAG 
Cm qPCR (s) qPCR to measure copy number of cat 
in genome or in plasmids 
CGCCTGATGAATGCTCATCC 
Cm qPCR (a) qPCR to measure copy number of cat 
in genome or in plasmids 
AGGTTTTCACCGTAACACGC 
bioA qPCR (s) qPCR to normalize cat copy number to 
number of copies of genome  
GTGATGCCGAAATGGTTGCC 
bioA qPCR (a) qPCR to normalize cat copy number to 
number of copies of genome 
GCGGTCAGACGCTGCAACTG 
 142 
 
Amplification of the construct was accomplished by 
subculturing the resulting strains in LB (1:100), increasing the 
chloramphenicol concentration in doublings from 13.6 µg/mL to 
the desired concentration (as high as 1,360 µg/mL).  recA 
deletion was accomplished by P1 phage transduction of the 
recA::kan allele to the TGD strain.  recA- was routinely 
validated by UV sensitivity to 3,000 µJ energy using a 
Stratalinker UV crosslinker (Stratagene, La Jolla, CA). 
pTGD
5628 bp
AmpR
CM(R)
Multicloning Site
Hom. Region
Hom. Region
pBR322 ori
BamHI (3814)
XbaI (1062)
SacI (1)
PstI (12)
MluI (35)
KpnI (20)
SphI (5622) XhoI (5628)
 
Figure 6-2: Plasmid map for pTGD. 
Hom Region- 1 kb DNA from Synechocystis used for recA-based DNA crossover. CM(R)- 
chloramphenicol acetyl transferase (chloramphenicol resistance), AmpR – betalactamase 
(ampicillin resistance), ori – origin of replication. 
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6.2.3. Subculturing genetic stability assay 
Strains were grown in 5 mL LB in 14 mL culture tubes at 37oC 
without antibiotics.  After cultures reached stationary phase 
(typically ~12 hrs), 50 µL were diluted into a fresh 5 mL of LB 
(100x dilution).  This was repeated a total of seven times.  At 
which point, genomic DNA was purified and copy numbers measured 
by qPCR.  A sample of the cells was grown in MR medium for 3 
days and PHB analyzed. 
6.2.4. Exponential phase genetic stability assay 
Cells were cultured by continous subculture.  Cells were 
grown in 250 mL erlyenmeyer shake flasks with 50 mL MR media at 
37oC and 225 rpm.  Cells were innocculated at A600=0.015 and were 
allowed to grow to late exponential phase (typically A600 = 2.0).  
Cells were subcultured by innocculating the culture to A600=0.015 
in a prewarmed shake flask as above.  By this, cells were 
continuously growing at maximal growth rate and did not enter 
stationary phase during the course of the experiment.  Specific 
growth rate was estimated in each subculture based on the A600 
data points taken. PHB accumulation was measured as below and 
used to calculate PHB productivity as the product of specific 
growth rate and PHB accumulation, an approximation that holds at 
steady state.  
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6.2.5. qPCR measurement of copy number 
Copy numbers were detected by qPCR on genomic DNA isolated 
from the appropriate strains using the Wizard Genomic 
Purification kit (Promega).  qPCR was carried out on a Biorad 
iCycler using the iQ SYBR Green Supermix (Biorad).  cat copy 
numbers was detected and compared to the copy number of bioA, a 
nearby native gene in the genome.  Table 6-1 has primers used 
for qPCR.  Genomic DNA containing only one copy of the construct 
was diluted and used as a standard curve. 
6.2.6. Poly-3-hydroxybutyrate Assay 
End point PHB accumulation of the strains was determined by 
inoculating an overnight culture of LB (1% v/v) into a 250 mL 
shake flask with 50 mL of MR media.  Cells were cultured at 37oC 
for 72 hrs at 225 rpm.  Cells were harvested by centrifugation, 
and PHB content was analyzed by hydrolysis to crotonic acid 
followed by HPLC analysis as described in Chapter 3.2.3. 
6.2.7. FACS Assay 
Percentage of cells producing PHB was determined by 
fluorescence activated cell sorting (FACS) using nile red to 
stain the PHB granules.  Samples were collected from the 
exponential phase subculturing experiment, and allowed to grow 
to late stationary phase (to maximize the PHB in a cell).  200 
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µL of cell culture was mixed with 800 µL isopropanol to fix the 
cells.  This was incubated for 10 min and then resuspended in 10 
mg/mL MgCl with 3 µg/mL nile red.  Cells were stained with nile 
red for 30 min in the dark and analyzed on a Becton Dickinson 
FACScan.  Cells were scored as containing PHB if the 
fluorescence was above the 95th percentile of a distribution of 
cells containing no PHB. 
6.3. Results 
A DNA construct that would promote gene duplication via TGD 
on the E. coli genome was constructed.  A shuttle plasmid, pTGD, 
was constructed that would deliver the required DNA elements to 
the genome with the λInCh genomic integration system (Boyd, 
Weiss et al. 2000) (details in Materials and Methods).  pTGD 
contains two identical, non-coding 1 kb regions of Synechocystis 
DNA flanking cat and a multicloning site.  Upon delivery to the 
genome of recA+ E. coli, the construct was amplified by serial 
subculturing in increasing concentrations of chloramphenicol 
resulting in higher chloramphenicol tolerance due to more copies 
(called TGD(cat)) (Figure 6-3).  In equivalent recA- strains, 
increased resistance to chloramphenicol could not be induced by 
serial subculture (Figure 6-3).  A second strain was created 
with the PHB operon cloned into the multicloning site of pTGD 
(called TGD(cat + PHB)).  It behaved the same as TGD(cat) in 
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response to chloramphenicol depending on the recA genotype 
(Figure 6-3). 
 
The stability of copy number was determined by subculturing 
the strain seven times (~45 generations) in the absence of 
antibiotics for plasmids and TGD(cat) constructs (Figure 6-4(a)).  
As expected, the plasmid copy number was significantly reduced.  
Tandem gene constructs, both recA+ and recA-, faired much better 
and did not have reduced copy number.  To impose conditions that 
place a metabolic burden on the cell due to increased copy 
number, and increase the growth disadvantage of recombinant 
expression, the PHB-containing strain was subjected to the same 
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Figure 6-3: recA is required for copy number amplification. 
TGD strains with and without recA were subcultured in antibiotics.  For strains that were 
recA+, amplification occurred, as additional copies could be made through recA-mediated 
recombination.  recA- strains could not do the recombination, and therefore not increase their 
copy number. 
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subculturing as above (Figure 6-4(b)).  With the PHB operon, the 
plasmid copy number had been reduced to less than 0.1 %.  The 
TGD (cat + PHB) recA+ strain copy number was reduced, due to the 
possibility for the DNA crossover event to reduce the copy 
number.  However, the reduction was not as dramatic because DNA 
crossover, which occurs in ~10-2 cells, or ~7 generations, for 
high homology regions (Anderson and Roth 1981), is not expected 
to be as frequent as segregation.  The TGD(cat + PHB) recA- 
strain was not able to reduce its copy number, even with the 
selection pressure imposed by the PHB operon.  The ability of 
recA to act as an ‘on/off’ switch for changing copy number 
represents an important control to determine and set the copy 
number.  The PHB accumulation in late stationary phase tracked 
with the copy number measurements of the strains (Figure 2(c)).  
The plasmid made almost no PHB after subculture, while the 
TGD(cat + PHB) recA- construct produced the same amount of PHB 
as before subculture.  This confirms that the gene copies are 
both present and active after many rounds of subculture in TGD 
recA-strains. 
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To test the long term PHB productivity, TGD(cat + PHB) 
recA- was maintained in exponential phase by subculturing for 70 
generations without antibiotic maintenance and compared to 
plasmid-based PHB strain with antibiotic maintenance.  Unlike 
the prior experiment, the plasmid-based strain (but not the TGD 
strain) will be grown in the presence of antibiotics, requiring 
the resistance cassette to be active, but not necessarily the 
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(a) Copy numbers before and after seven rounds of 
subculture for identical constructs of cat that were 
expressed as multiple copies on (1) a plasmid, (2) 
multiple tandem genes in a recA+ strain or (3) 
multiple tandem genes in a recA- cell without 
antibiotics.  (b) As above, except all strains contain 
cat and the PHB operon, which significantly reduced 
the growth rate associated with the multiple copies 
of each gene, allowing cells with loss of PHB 
activity to have a growth advantage.  (c) PHB 
accumulation before and after seven rounds of 
subculturing.  Plasmids were lost even without the 
burden of PHB, while a recA+ tandem gene 
construct lost copies at a slower rate than plasmids.  
TGD recA- constructs were stable for the length of 
the experiment in all cases.  Copy numbers were 
measured by qPCR on DNA extractions before and 
after the subculturing.  Copy number was determined 
by the ratio of copies of cat (on plasmid or in TGD) 
compared to the genome (as measured by a gene 
near the integration site, bioA). 
 
Figure 6-4: TGD recA- is more stable than plasmids or TGD recA+ without antibiotics. 
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PHB operon.  Figure 6-5 shows the growth rates, specific PHB 
productivity, and percentage of cells producing PHB over time 
for the two strains.  Without antibiotics, PHB productivity of 
the plasmid system went to zero in five doublings (data not 
shown).  The average specific growth rate of the TGD strain was 
0.44 h-1 compared to 0.58 h-1 for the same strain without PHB 
production.  This difference in growth rate would provide a 
driving force for a mutant population to overtake the culture 
had it occurred.  The plasmid system evolved to the maximal 
growth rate in 40 generations, which was accompanied by a loss 
of PHB productivity.  The TGD system maintained >90% of its PHB 
productivity up to 70 generations.  PHB plasmid maintained 
resistance to the antibiotics throughout the subculture, however, 
PHB only 20% of the cells were producing any PHB.  An estimated 
27 generations had passed from the cell transformed with the 
plasmid until the beginning of the subculturing experiment, 
making the total of 67 generations in line with the estimates of 
Appendix I.  This shows that TGD constructs without selection 
pressure maintain recombinant expression for much longer than 
plasmids, even when antibiotic selection is present. 
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The ability to control gene dose is a useful variable for 
metabolic engineering and synthetic biology, because it allows 
precise control over expression.  By varying the concentration 
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TGD (cat + PHB) recA- and K12 recA-
(pZE-tac-pha), referred to as Plasmid, 
were subcultured to maintain 
exponential phase for 70 generations. (a) 
Specific growth rate change with 
subculturing.  Line is TGD cat recA-
strain (with no PHB).  Significant 
differences in growth show a selection 
pressure to evolve to a growth rate faster 
than was allowed under that PHB 
production conditions.  However, even 
with a possible 25% improvement in 
growth rate, no faster growing mutants 
emerged for the TGD strain.  This is 
compared to 40 generation for the 
plasmid-based PHB system.  (b) PHB 
specific productivity in exponential 
phase.  TGD(cat + PHB) maintains 90% 
of the PHB productivity throughout and 
at a significantly higher level than the 
plasmid tested.  Plasmid-based PHB 
system lost all measurable productivity 
by 40 generations.  (c) Percentage of 
cells producing PHB.  Flow cytometry 
used to quantify nile red-stained PHB 
content in cells.  Percentage is fraction 
of the population that fluoresced higher 
than the 95th percentile of a 
fluorescence distribution for the negative 
control.  TGD (cat + PHB) recA- – strain 
as above. Plasmid – K12 recA- (pZE-
tac-PHB).  Generations based on the 
doubling time of the parent strain.
 
Figure 6-5: Long term performance of tandem PHB operon. 
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of antibiotic used during the amplification, a range of copy 
numbers could be produced.  Figure 6-6 shows the effect of 
chloramphenicol on copy number in the constructs.  Without the 
PHB operon, the copy number reaches a maximum of 45 copies with 
a linear range from 0 – 500 µg/mL chloramphenical.  With the PHB 
operon, there is an upward trend in copy number throughout the 
range of antibiotics used, did not increase beyond ~25 copies.  
It is possible that the PHB operon limits the copy number that 
is achievable.  This is most likely due to the competition 
between the growth advantage due to the increase copies of the 
cat gene working against the growth disadvantage caused by an 
increase in the copies of the PHB operon.  At low copy number, 
the increased growth advantage by an additional copy number of 
cat outweighs the disadvantage of more PHB operons.  However, at 
higher copy number, the reverse becomes true, and the copy 
number reaches an equilibrium that is lower than if the PHB 
operon is not present. 
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6.4. Discussion 
Tandem genes offer a superior method for high copy 
expression in many respects.  Most importantly, TGD avoids 
allele segregation, thereby circumventing the shortest step to 
the propagation of mutant alleles.  This is achieved by linking 
all of the copies on a single strand of DNA in the genome.  By 
linking them in the genome, each daughter cell is guaranteed to 
receive one copy of each of the tandem genes.  Therefore, the 
mechanism for losing recombinant expression is by DNA copy 
errors, which has been predicted to be much slower than allele 
segregation.   
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Figure 6-6: Copy number of TGD can be varied fined-tuned expression. 
Strains were amplified to different copy numbers by growing them at different 
concentrations of chloramphenicol before deleting recA.  (a) Copy number of cat in 
genome. (b) PHB accumulation. 
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As well, some properties of TGD are uniquely useful for 
synthetic biology and metabolic engineering.  The copy number of 
the tandem genes is constant, due to it being in the genome, 
compared to plasmids of which a growing population will have a 
distribution of copy numbers (Bentley and Quiroga 1993).  
Additionally, if plasmids with relaxed origin of replications 
are used for expression, the copy number can vary greatly 
between growth and stationary phase (Paulsson and Ehrenberg 
2001).  In synthetic control circuits, a transient variation in 
copy number could be problematic in the control scheme, leading 
to unintended responses and artifacts in the circuit.  Because 
of the constant copy number, TGD should be helpful in the design 
of gene circuits employed in synthetic biology studies.  
Furthermore, the copy number can be tuned by the strength of 
antibiotic used for the gene amplification step as shown above.  
This is equivalent to tuning promoter strength and allows for a 
continuous range of expression for a given gene by controlling 
the copy number.  This control over expression is also 
attractive for finely tuned genetic circuits. 
Tandem gene constructs meet many of the other properties of 
plasmids.  Unlike other genomic integration approaches that are 
limited to one copy, the copy numbers of TGD can be varied over 
much of the same range as plasmids.  This is shown both in the 
measurement of copy number and in PHB productivity, verifying 
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that high expression is possible.  As with the par locus or 
auxotrophic markers, the tandem genes can be propagated without 
any external antibiotic.   
Unlike prior attempts to engineer TGD, this method uses 
recA as an ‘on/off’ switch to control the change in copy number 
of the tandem genes (Olson, Zhang et al. 1998).  Without the 
deletion of recA, the utility of the TGD constructs would be 
extremely hindered as copy number would decrease over time.   
Allele segregation must be avoided for long term expression.  
While minimal genome approaches promise increased genetic 
stability by removal of transposons, prophage, and other genetic 
loci that would otherwise increase the mutation frequencies 
(Kolisnychenko, Plunkett et al. 2002), the fidelity of DNA 
polymerase, and associated DNA repair mechanisms, which are not 
expected to be improved by minimal genomes, ensure that DNA 
mutations will eventually arise.  If the limiting time scale of 
mutation propagation is allele segregation, these improvements 
in DNA mutation frequency will have little effect on the 
longevity of plasmid expression in these synthetic strains.  
However, multiple copies of the desired pathway in the genome, 
as achieved by TGD, will be much more stable. 
TGD could be deployed in many different biotech 
applications.  TGD constructs could be particularly useful in 
the production of low-value added commodity chemicals.  
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Continuous processes have inherent economic advantages over 
batch processes, but have not traditionally been used in the 
biotech industry because of issues with sterility and genetic 
mutation.  TGD significantly extends the time that recombinant 
genes can be expressed in continuous systems and may prove 
useful in low value products such as biofuels.  Tandem gene 
duplication events are ubiquitous in nature, and could therefore 
be applied in many prokaryotic and eukaryotic host organisms, by 
delivering analogous DNA constructs and inactivating recA 
homologues.  We expect this method to have wide industrial 
application for recombinant expression because of the stability, 
high expression, and lack of need for plasmid maintenance.  In 
the case of PHB production, where high expression levels will 
inhibit PHB production, due to large diversion of carbon to PHB, 
as seen by the stoichiometrically maximal calculations (Figure 
5-4), TGD stands to make a significant difference in how long 
PHB accumulation can be sustained. 
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7 Conclusions and Recommendations 
7.1. Conclusions 
This study identified genetic changes that would increase 
poly-3-hydroxybutyrate accumulation in two systems using two 
methodologies.  Specifically, forward metabolic engineering 
(FME) and inverse metabolic engineering (IME) methodologies were 
used to set up a framework for choosing or identifying these 
genetic changes in (A) a photosynthetic system (Synechocystis), 
using light and carbon dioxide and a native PHB pathway, or (B) 
a heterotrophic system (E. coli), using sugar and a recombinant 
PHB pathway.  This latitude of biological system and approach 
shows the necessity of multifaceted approaches to strain 
improvement, and this study has shown that synergies can be 
exploited between the different approaches. 
For IME approaches, methods were developed to introduce 
transposons into Synechocystis.  These transposon libraries can 
serve as a resource for screening other phenotypes in a 
photosynthetic system.  For the purposes of this study, a screen 
for PHB was developed.  Careful optimization of salt 
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concentrations and permeabilization methods made it possible to 
have a quantitative relationship between nile red fluorescence 
and PHB accumulation, while keeping the cells viable.  This 
method, in conjunction with fluorescence activated cell sorting 
(FACS), allowed large transposon libraries of Synechocystis to 
be sorted, and mutants with increased PHB to be isolated.  
Through this, it was determined that two genes, proA and sll0565, 
would increase PHB accumulation in a variety of conditions, and 
led to the hypothesis that proline and osmolyte balancing may 
play an important role in the regulation of PHB accumulation in 
Synechocystis.  However, IME strategies failed to increase PHB 
production in E. coli.   
FME strategies in E. coli were employed and focused on the 
effect of changing expression levels in the product-forming 
pathway and engineering ways of improving genetic stability.  As 
mentioned, IME strategies, analogous to those carried out in 
Synechocystis, did not reveal changes in the genome that would 
increase PHB production in E. coli.  We hypothesized that 
expression levels in the product-forming pathway controlled the 
flux from acetyl-CoA to PHB (these expression levels would not 
likely be perturbed in the mutagenesis methods used for IME in 
this study).  Systematic overexpression of the three steps in 
the product-forming pathway revealed that phaB, the acetoacetyl-
CoA reductase, exerts the most flux control over the pathway.  
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Beyond this, increased expression of the entire pathway allowed 
even higher flux levels.  This implies that, after phaB, other 
expression limitations in the pathway exist.  High PHB pathway 
expression increased PHB flux, but the high PHB/biomass ratio 
severely reduced growth rate, allowing PHB-deficient mutants to 
quickly overtake the culture. 
To reduce mutation problems, tandem gene duplication was 
developed.  It was hypothesized that the propagation of mutated 
alleles in multicopy plasmids from (a) the first mutant plasmid 
among many native plasmids to (b) all plasmids being a copy of 
the mutant was much faster than DNA copy errors.  Probabalistic 
calculations predicted this was primarily a result of the random 
distribution of plasmids from mother to daughter cells coupled 
with an increased growth advantage for more copies of the mutant 
allele, termed ‘allele segregation.’  Tandem genes avoid allele 
segregation by having all copies in tandem on the genome, 
forcing ordered inheritance of each copy of the allele.  
Calculations predicted a 10 fold increase in genetic stability, 
and experiments found at least a 3 fold increase.  TGD does not 
require antibiotics, have a stable copy number, and expression 
can be tuned over a range of copy numbers.  The increased 
genetic stability will make chemostats more attractive, as 
fermentations can be extended beyond what would be possible with 
plasmids. 
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Aside from commenting on the specific conclusions of PHB 
production in microorganisms, it is helpful to comment on the 
use of forward and inverse metabolic engineering strategies in a 
strain improvement program.  FME will always be more effective 
when the amount of information in a system is high.  Forward 
approaches lend themselves to hypothesis driven experiments, 
where a negative result can be as definitive as a positive 
result (which is not the case in IME screening experiments).  
Forward approaches also focus on a few measurements guided by 
relevant hypotheses.  Typically, experimental methods for 
measuring few samples are more available than measuring many, as 
is required by screening approaches (This can require 
significant effort to develop an effective screen for metabolic 
engineering applications).  But forward approaches can only be 
engineer systems to the extent of what is known. 
Inverse strategies, by converse, do not need the amount of 
information that forward strategies need.  These approaches rely 
on being able to test many hypotheses rapidly (such as the 
hypothesis that each gene in the genome increases PHB), 
uncovering relationships that were not previously known.  IME 
adds distal knowledge, by asking many global hypothesis that can 
be answered simultaneously.   
FME and IME work best in parallel, allowing information 
gathered from IME to direct FME experiments.  This was 
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particularly true for E. coli.  Although literature implied 
precursor shortages limited PHB, by performing the global IME 
studies, it was hypothesized that other constraints were 
limiting the system, leading to the first experimental 
determination that flux control in the PHB pathway is limiting.  
It is our hope that likewise, the information from the 
Synechocystis study will be useful to researchers studying PHB 
metabolic engineering in plants. 
7.2. Recommendations 
With regard to further engineering of Synechocystis, the 
most interesting pursuits would be to apply the knowledge 
gathered in this thesis to PHB production in higher plants.  
Commercial production of PHB in Synechocystis is unlikely to be 
economical, due to high capital costs for light bioreactors.  
However, plants, which can be cultivated at lower costs, may be 
attractive, although yields are currently prohibitively low.  Of 
particular interest is the investigation of the effects of 
proline biosynthesis and/or osmolyte stress on PHB accumulation 
in higher plants.  This is outside the expertise of our lab, but 
we hope appropriate researchers may find our results useful. 
PHB production in E. coli shows much promise, and indeed 
has already been implemented industrially (Kennedy 2007).  
Questions have been left unanswered concerning why the activity 
 162 
of the PHB pathway is so low, given the high copy number of the 
operon.  While high flux was achievable with increased 
expression, enzyme activities need to be carefully studied for 
allosteric regulation, and when possible deregulate the enzymes 
by amino acid level mutagenesis.  Understanding and engineering 
these enzymes may increase PHB flux without the need for very 
high levels of expression and may minimize other secretion 
products, such as acetate. 
The observation that PHB productivity can be controlled by 
expression of the PHB operon allows for many possible modes of 
operations (Chapter 6 Discussion).  As continuous processes may 
be attractive, further work on one-step or two-step chemostats 
will likely answer those questions.  Studying glucose-limited 
chemostats, and running chemostats with strains that have 
different PHB operon expression levels will reveal if yields and 
productivities can be achieved that would make these processes 
commercially attractive.  Glucose-limited chemostats may also 
have reduced acetate production. 
Tandem gene duplication should find application in several 
metabolic engineering systems.  Tandem genes will be most 
advantageous in applications that require many doublings of the 
cells and where growth is significantly reduced by the 
recombinant expression.  The copy number attainable by TGD 
appears to be limited by the growth disadvantage associated with 
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high copies of PHB.  One way to overcome this would be to 
repress the PHB genes (or other genes of interest) during the 
TGD amplification step.  This would allow the copy number to 
increase without the growth disadvantage imparted by each new 
copy of the gene of interest.  After recA deletion has been 
completed, the repression can be removed, and all copies will 
have full expression.  This should increase the attainable copy 
numbers, and thereby the expression levels.   
Tandem gene duplication should be very useful as metabolic 
engineering shifts from a paradigm of high value products, such 
as biologics and specialty chemicals, to low value products, 
like commodity polymers and biofuels.  TGD does not require 
antibiotics in production and more importantly the ability to 
stay productive for long periods in chemostats should 
significantly reduce production costs. 
In general when planning a strain improvement program, we 
would propose a strategy of (A) doing forward metabolic 
engineering to the extent possible on the wild type strain using 
available data.  In parallel with this, develop methods for 
mutagenesis and screening of the desired phenotype using the 
wild type strain.  After FME options have been exhausted, (B) do 
inverse metabolic engineering (using the IME methods developed 
in (A)) on the current-best engineered strain.  New genetic loci, 
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identified in (B), should be investigated in detail, using FME 
approaches. 
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Appendix I – Kinetic model of PHB pathway 
The PHB pathway was analyzed using the model by van Wegen, 
et. al. (van Wegen, Lee et al. 2001).  Details of model are in 
paper. 
Matlab code for kinetic model 
function x = PHB(rmax_A, rmax_B, A); 
 
%Keith Tyo 
%10/23/06 
 
%Parameters and equations taken from  
%van Wegen, et. al.  Biotech. & Bioeng.  74(1) 70-80 
 
% Will be solving 3 equations for 
% (1) flux [r] (2) acetyl-acetyl-CoA conc [AA] (3) 3-HB conc [HB] 
 
% Will be optimizing flux by varying rmax_A and r_max_B activity. 
 
 
%Solved for concentrations 
%Initial Guess 
AA = 0.14; 
HB = 27.5; 
 
%Activities 
%rmax_A = 2; 
%rmax_B = 2.6; 
rmax_EC = 0.7653; % This one will be set 
 
rmax = [rmax_A 
        rmax_B 
        rmax_EC]; 
 
%Metabolite concentrations 
%A = 475; %uM 
C = 47.5; % based on a AcCoA/CoA = 10 
P = 60; 
PH = 240; 
pH = 7.6; 
 176 
 
metab = [   A 
            C 
            P 
            PH 
            pH]; 
 
     
%Optimization variable 
r = 0.5; 
 
%Find zeroes of function 
xo = [   r 
        AA 
        HB]; 
 
options = optimset; 
     
x = fsolve(@kin_eqn, xo, options, rmax, metab) 
     
return; 
     
function X = kin_eqn(xo, rmax, metab) 
 
rmax_A = rmax(1); 
rmax_B = rmax(2); 
rmax_EC = rmax(3); 
 
A = metab(1); 
C = metab(2); 
P = metab(3); 
PH = metab(4); 
pH = metab(5); 
 
%Constants 
Keq = 500*10^(7.2-pH); 
 
r = xo(1); 
AA = xo(2); 
HB = xo(3); 
 
X = zeros(1,3); 
 
X(1) = rmax_A*(A^2-25000*AA*C)/(840*A+A^2+67.7*A*C)-r; 
 
X(2) = rmax_B*(AA*PH-
1/Keq*P*HB)/(95+19*AA+5*PH+AA*PH+2897/Keq*HB+1532/Keq*P+93/Keq*HB*P)-r; 
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X(3) = rmax_EC*HB/(720+HB)-r; 
 
return; 
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Appendix II – Plasmid propagation model 
Plasmid System 
 
We’ll assume the propagation of a mutation that overtakes a 
population can be characterized by three steps. 
1) DNA replication error 
2) Propagation of mutated plasmid to form subpopulation with 
only mutated plasmid 
3) Overtake of parent population by mutant population 
 
Assumptions 
40 copies of a plasmid 
Each plasmid contains a 5 kb region of expression 
 
DNA replication error 
Estimate of DNA Mutation Rate 
Although apparent DNA mutation rates can vary widely (10-11 
to 10-6 errors/bp copied) given the state of the cell or location 
of the DNA, 5.4×10-10 errors / bp copied [or 1 error every 
1.85×109 bases copied] is a basal DNA mutation rate consistent 
with many observations(Drake, Charlesworth et al. 1998; Taft-
Benz and Schaaper 1998; Burger, Willensdorfer et al. 2006). 
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However, not every mutation can be expected to result in a 
loss of function for the enzyme.   
 
Expectation of number of doublings for one mutation 
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It is expected that one copy will be mutated in ~13 
doublings.  If grown from a single cell, that means 1 cell in 
8,192 will be mutated. 
 
Propagation of mutant plasmid 
A simple segregated subpopulation balance model was used to 
estimate the relative abundance of subpopulation that differ in 
the number of copies of the mutant plasmid for a given number of 
generations and an initial distribution of mutant plasmid copy 
numbers.  The model assumes a binomial distribution of plasmids 
from mother to daughter cells.  This distribution will be 
weighted at each division by a linear growth advantage that 
favors cells with more of the mutant allele plasmids.  This 
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model is a theoretical simplification of a model by Bentley & 
Quiroga that assumes plasmids replicate at the same rate as the 
cells, as would be expected for steady state(Bentley and Quiroga 
1993).  The unmutated plasmids are not explicitly accounted for 
in this model. 
 
The binomial distribution was taken as  
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Where δij is the probability that a mother cell with j 
plasmids generates two daughter cells, one with i plasmids one 
another with j-i plasmids.  The 2j term is used because it is 
assumed the plasmids double at the same rate as the cells do, as 
would be expected at steady state growth. 
 
The model was used to account for the number of mutated 
plasmids in a given cell.  The dependence of growth rate on 
plasmid copy number was assumed to be linear and increase with 
increasing number of mutant plasmids. 
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C  = Number of mutant copies of plasmid 
µ  = Growth rate of strain with C mutant copies 
µfast = Growth rate of strain containing only mutant 
plasmids (0.32 h-1) 
µslow = Growth rate of strain containing only original 
plasmids (0.15 h-1) 
Cmax = Copy number of plasmid (40) 
 
Values for difference in µfast, µslow , and Cmax were based on 
experimental observations of a PHB strain, before and after loss 
of PHB productivity. 
 
Matlab software package was used to iterate the number of 
generations (see below for code).  Briefly, a vector, N, whose 
elements, i, are the number of cells with (i-1) mutant plasmids.  
This vector is expanded to N_doub, where each element is moved 
two twice its index, except the zero plasmid (i=1).  N_doub is 
multiplied by the matrix of the binomial distribution to 
calculate the new distribution of plasmids.  This distribution 
is weighted by the linear growth advantage before iterating for 
n generations. 
These results are for a starting distribution of 1 cell 
with 1 mutant plasmid (the 0th population is not plotted to 
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maintain scale features).  By the 20th generation a mutant 
plasmid subpopulation has formed and broken away from the 
parental population. 
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Depending on the expression used for plasmid replication 
rate, the segregation to a cell only containing mutant plasmids 
would take ~20 doublings.   
 
Overtake of parent population by mutant population 
Once a second population of mutant plasmids has segregated, 
the ratio of mutant to parental populations follows this 
expression 
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An initial ratio of 1 mutant and 1.3x105 parental cells 
(based on 17 doublings of the parental strain) and the specific 
growth rates used above, it was estimated to take 69 hrs or 15 
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doublings of the parental strain for the mutant to overtake the 
population. 
 
This is also predicted by the distribution model.  
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Matlab code for propagation model 
function [N_running] = binomial(n) 
% This population balance model consist of a vector, N, with i indices, where each element has copy 
% number (i-1) of the mutant plasmid.  At each generation, the probability 
% of daughter cells inheriting a given copy number is calculated for each 
% mother cell subpopulation and summed.  The distribution of copy numbers 
% is then weighted by a linear function that gives a growth advantage for 
% increased copies of the mutant plasmid. 
 
% The unmutated plasmid is not specifically accounted for in this model, 
% and the total number of plasmids is assumed to be at steady state (as in 
% the plasmids replicate at the same rate as the cells). 
 
% The starting distribution is based on the DNA mutation rate calculations 
% that it will take 13 generations for a mutant to arise, leading to 1 
% mutant in 2^13 ~8192.  
 
% This function iterates a binomial distribution of plasmids from mother to 
% daughter cells.  It is weighted at each generation by a growth advantage 
% observed for XL1 Blue growing with  
%   (a) pZE-tac-pha [Specific growth rate = 0.15 h-1] 
%   (b) null PHB mutant of pZE-tac-pha [Specific growth rate = 0.32 h-1] 
%  The copy number for this plasmid is ~40 in exponential phase. 
 
% The input n, is the number of generations to calculate. 
 
 
 
% Max concentration of plasmids / cell (ie max calculated copy number) 
Npmax   = 85;  %Arbitrary, but must be high 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
 
% Plasmid segregation - binomial distribution 
 
for j=1:Npmax+1 
    i = 1; 
    while i-1 <= 2*(j-1) 
        deltaij(i,j) = (factorial(2*(j-1))/(factorial((2*(j-1))-(i-1))*factorial(i-1)))*0.5^(2*(j-1)); 
        i = i + 1;     
    end 
end 
 
% Truncate probabilities for copy numbers above maximum copy number 
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trunc_prob = sum(deltaij(Npmax+1:2*Npmax+1,:)); 
deltaij(Npmax+1,:) = trunc_prob; 
deltaij(Npmax+2:2*Npmax+1,:) = []; 
 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
 
% Set growth advantage matrix 
slope = (.32 - .15)/(Npmax - 0); % Based on experimental observation 
int = .15; % Based on experimental observation 
 
% Make linear growth advantage from slope and intercept given. 
y = zeros(Npmax+1,1); 
 
for x=1:Npmax+1 
    y(x) = x*slope + int; 
end 
 
for i=1:Npmax+1 
    G(i,i) = y(i); 
end 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
 
% Vector of starting distribution 
No = zeros(Npmax+1,1); 
 
% Distribution based on DNA mutation rate calculation 
No(2) = 1; 
No(1) = 8192; 
 
% Normalize distribution 
No = No/sum(No); 
 
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%% 
 
%Propogate n times 
 
disp('Number of Generations'); 
disp(n); 
 
i = 1; 
 
while i <= n 
     
    N_running(:,i) = No; 
     
    N = G*deltaij*No; 
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    % Normalize N 
    N = N./sum(N); 
     
    No = N; 
    i = i+1; 
end 
 
plot(N) 
 
return 
